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Abstract 
Despite the nature of asthma and its complexity, there is an improvement in understanding 
of its pathophysiology, better diagnosis and more availability of effective anti-
inflammatory therapy. However, emergency rooms (ERs) usage due to asthma attacks, is 
highly common and represents an important place where specialized health care delivery is 
needed. Further, the determinants for the attendance of asthma patients at the ERs and the 
possible effective interventions are one of the most observed public health problems in the 
world today. Yet, effective management and the extent to which intervention program 
should be applied to appropriately manage asthma and prevent ER frequent attendance will 
depend primarily on understanding why this occur. We sought to determine the risk factors 
for frequent attendance of asthma patients at ER of Alia hospital in Hebron district as 
baseline study for setting a future intervention program for proper asthma management and 
reduce ER attendance. 
In this study, we used a questionnaire, face to face interview, to collect information on 
socio-demographic factors, health services utilization information, medications prescribed 
and asthma severity criteria. We interviewed 121 patients  5 years old who attended the 
emergency room of Alia hospital through April to the end of May 2005 using the non-
random purposive sampling method. The study was approved by the scientific research 
committee at AL-Quds University, and a permission to conduct the study from Alia 
hospital's manager was obtained. A written informed consent was obtained from each 
participant or the parents.  
Participants were categorized into one time versus frequent ER attendees.  Also data was 
analyzed by asthma severity classification according to GINA 2002 guidelines. Univariate 
analysis was used to check for the significance of the association in using a chi-square p 
value less than 0.05. Multivariate analysis was used in for both ER attendance and chronic 
asthma severity outcome variables to determine the major determinants for both outcome 
variables. 
The mean age of the participants was 47 years, standard deviation 18.5 years, 53% males, 
and 77% were married. Of the 121 participants, 73.5% were frequent ER attendees, 54.5% 
had mild asthma and 45.5% had moderate/severe asthma. Asthma severity, indicators of 
severity (ever been admitted to hospital with asthma) and reporting difficulty in asthma 
inhalers/devices use were more likely to be associated with the frequent ER attendees. 
Patients living in cities and refugee camps showed six fold increased risk to be frequent ER 
attendees compared to villages (p> 0.05). We also found that most days regular intake of 
inhaled short B-agonist was significantly more likely to be associated with frequent 
attendees and moderate/severe asthma compared to none regular use. For asthma severity, 
hospital admissions in less than a year ago and number of admissions (1-2 times or 3-4 
times compared to no admission) were a strong risk factor. Under-treatment with inhaled 
beclomethasone, get regular treatment, follow up with patient carer, inability to obtain 
asthma medicines, using other remedies for asthma, most day regular intake of oral 
theophyline, and using 10-15 courses per year of oral steroids were more likely to be 
associated with moderate/severe asthmatics. On the other hand, reporting beneficial results 
from doctor in managing asthma at home, and an occasional regular intake of inhaled 
steroid were less likely to be associated with moderate/severe asthmatics. Married and 
older ages ( 50 years) patients were more likely to have moderate/severe asthma 
compared to single and younger ages (5-19 years) patients. Meanwhile, higher levels of 
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schooling ( 10 years) and being on a monthly-based salary employee were less likely to 
have moderate/severe asthma compared to lower level of schooling (0-6 years) and being 
unemployed. 
In conclusion, frequent ER attendees represent a group of asthmatic patients with 
moderate/severe, poorly controlled and managed asthma. Having access to health services 
does not necessarily ensure a good quality of care and proper treatment. However, low 
socio-economic status contributes to asthma morbidity in Palestine. Further, compliance 
and adherence to asthma medications should be considered for patients attending the ER 
for asthma especially those with the more sever disease.  Lack of inhalers/devices proper 
use is a major problem for patients with asthma in Palestine. Meanwhile, over-reliance on 
reliever therapy rather than controller therapy added an increased risk for frequent ER 
usage and asthma morbidity.  
We strongly recommend an ER and/or PHC based asthma educational intervention 
program with an integral activity of all health workers concentrated mainly on proper 
usage of asthma inhalers/devices, as well as a training program for health professionals on 
proper pharmacotherapy of asthma. Exploring the barriers to financing and asthma 
medications could further stratify targeted interventions in reducing the ER attendance for 
asthmatics, and would increase patients' compliance and adherence to prescribed 
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effectiveness of patient's cough (AAAAI, 2006).  
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Chapter 1 
Background and Significance 
1.1 Background 
Asthma is a chronic inflammatory disorder of the airways that is characterized by recurrent 
episodes of wheezing, breathlessness, chest tightness, and coughing, particularly at night or 
in the early morning (NHLBI, 1997).  It is considered as a major public health issue, and 
one of the most common chronic diseases worldwide. Globally, the prevalence of asthma 
continues to escalate with more than 300 million people around the world currently 
suffering from asthma. There  was an increased burden on the  health care systems, 
families, and patients by this disease and its consequences (NHLBI, 2003) with  the 
increasing morbidity and mortality rates worldwide (McFadden and Warren, 1997; Downs 
and Marks, 2001; Woolcock et al., 2001 ). 
Despite the nature of this disease and its complexity, there is an improvement in 
understanding its pathophysiology, better diagnosis and more availability of effective anti-
inflammatory therapy (Evans et al., 1987; Jackson et al., 1988). However, there is still a 
gap between the medical knowledge, therapy and its utilization for the benefit of the 
asthmatic population (ECRHS, 1996). In addition, asthma continues to be under-
diagnosed.  In terms of its management, both under treatment and over treatment differ 
from that recommended by national and international guidelines commonly occur (Cerveri 
et al., 1997; Jansen et al., 1997; Rickard and Stempel, 1999; Lagerlov et al., 2000; Rabe et 
al., 2004). Thus, these issues represent a great challenge for the primary health care 
systems, particularly in developing countries such as Palestine (Anis et al., 2001; Piecoro 
et al., 2001; GINA, 2002). 
As any serious health condition, asthma can rapidly deplete the family financially and 
emotionally.  Asthmatic patients usually have diminished employment opportunities, 
which results in a low socio-economic status to those patients (Mitchell et al., 1989). Thus, 
reducing and controlling asthma can be conceived as an intervention to strengthen families, 
and yield not only healthier people but also improved family functioning, workplace 
productivity, and over all family well-being (Ait-Khaled et al., 2001).  
In most countries, especially in developed countries, such as Canada, USA, Australia and 
England, asthma affects more than 10% of both children and adults, although in 
developing countries asthma appears to be less prevalent ranging from 9.5% in Uruguay to 
5.5% in Iran and 3.8% in Morocco (Beasley, 1998). In the Middle East the mean 
prevalence of asthma is 5.8% while in North Africa it is 3.9% (Beasley, 1998). The 
number of disability adjusted life years (DALYs) lost due to asthma worldwide has been 
estimated to be currently about 15 million per year. Worldwide, asthma accounts for 
around 1% of all DALYs lost, and accounts for about 1 in every 250 death, and nearly 90% 
of cases involve avoidable factors (WHO, 2002).  In developed countries such as USA, 
asthma accounts for 5000 deaths annually, and almost 2 million emergency room visits 
(Weiss et al., 1992). Those discharged from the ER, approximately 10% to 20% will 
relapse within the subsequent 2 weeks (Camargo, 1998-a ; Camargo, 1998-b).   In 
comparison, in developing countries, statistical data related to costs and numbers of deaths 
or ER visits due to asthma are shortage.  In Egypt, for example; asthma is the most 
common cause of ER visits and hospital admission for respiratory complaint in adults, and 
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up to one in four children with asthma is unable to attend school regularly because of 
asthma. Further, in Mexico, the death rate due to asthma is over 4000 deaths per year 
(Beasley, 1998).   
In the Middle East, the available evidence indicates that the prevalence of asthma has 
increased over recent decades, but generally low compared to other regions (Ait-Khaled et 
al., 2001). High rates have been recorded in the Kingdom of Saudi Arabia, Kuwait, 
Lebanon, and Israel (Goren and Hellmann, 1997; Ait-Khaled et al., 2001; Al Frayh et al., 
2001).  For example, in Israel, a neighbouring country that shares the Palestinians the same 
environment, and despite improvements over recent years in the diagnosis and treatment, 
asthma related morbidity and mortality also continue to rise (Israel, MOH, 1997). In 
1994, the Israel Ministry of health statistics showed that  142 individuals (including both 
Jewish and Arabs inside Israel)  died of asthma in Israel,  one in five asthmatic children 
visits the ER per year, and one in ten asthmatic children is hospitalized in the same period 
due to severe asthma (Israel, MOH, 1997). 
In Palestine, respiratory diseases are one of the main causes of morbidity and mortality in 
children (Palestine, MOH, 1999). A series of studies on asthma determinant in childhood 
was carried out between the years 2000-2002 (EL Sharif, 2003) showed that children 
residing in refugee camps appear to be at greater risk of asthma compared to children from 
neighbouring villages and cities (EL-Sharif et al., 2002). These studies showed that the 
prevalence of 12 months wheezing among children aged (5-8) was higher compared to 
children aged (12-15) years (9.6% and 7.2% , respectively) (EL Sharif, 2003). The 12 
months wheezing prevalence rate was 8.8%, which varied among villages, cities and 
refugee camps (8.2%, 7.2% and 12.6%, respectively). 
1.1.1  Hospitalization of asthma patients: 
In USA, asthma is one of the major reasons for hospitalization of children and adults 
(Starfield et al., 1984; Halfon and Newacheck, 1986).  It has been estimated that asthma 
affects approximately 17.3 million Americans, including 5 million children <18 years of 
age (Mannino et al., 2002). It accounts for an estimated 23% of school absenteeism per 
year (Weiss et al., 2000; Mannino et al., 2002). Data indicating that the death rate from 
asthma increased 46% in the period from 1980 to 1989 are even more disturbing (Mannino 
et al., 2002). The 2001 statistic in USA, showed that approximately 0.5 million patients in 
the United States are hospitalized because of asthma, nearly 73% of hospitalization could 
be avoided with proper prior medical care (Asthma in America, 2001).  
In the Middle East, the hospital admission rates are in excess of 150-200 per 100,000 per 
year in some of the high prevalence countries (Goren and Hellmann, 1997; Ait-Khaled et 
al., 2001; Al Frayh et al., 2001). In Israel (including both Jewish and Arabs inside Israel), 
one in ten asthmatic children is hospitalized per year due to severe asthma (Israel, MOH, 
1997). 
1.1.2  Asthma studies in emergency rooms (ERs): 
Asthma in ERs was started to be of great interest in the past decade.   Several studies in 
Australia (Wakefield et al., 1997; Robertson et al., 1998), United States (Weiss et al., 
1992; Mannino et al., 2002), Europe (Cerveri et al., 1997; Jansen et al., 1997), Canada 
(Krahn et al., 1996) and other Middle Eastern countries (Goren and Hellmann, 1997; EL 
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Sharif, 2003), such as Saudi Arabia (AL Frayh et al., 2001), were concerned with asthma 
morbidity and mortality.  
The importance of studying asthma in ERs is that patients with asthma appearing in ERs 
are those who have sub-optimal treatment and those depending on the local management of 
patients in the community (Anis et al., 2001; Rabe et al., 2004). To get around this problem 
these studies  proposed a method to assess the extent of the local problem through the cases 
coming through the local ERs, so as they can devise and assess a tool for use in emergency 
rooms that will inform the local health services on the need for improving asthma 
management and identify the targets for improvement. 
Poorly controlled asthma is expensive, and emergency care for asthma represents the 
highest percent spent on this disease (Weiss et al., 1992). The major factors contributing to 
asthma morbidity and mortality are under-diagnosis and inappropriate treatment (Spitzer et 
al., 1992; Weiss and Sullvian, 1993). Thus, investment in prevention medication is likely 
to yield cost savings in emergency care and highlight the need to aggressively manage the 
disease and its symptoms (Kolbe et al., 1997).    
Despite the many international attempts and guidelines; e.g. GINA  guidelines (GINA, 
2002; NHLBI, 2003), to standardise and improve asthma care, wide gaps still remain 
between what is known to be effective treatment and what is practised (Cabana et al., 
1999). In addition, many barriers are still remain to reduce the burden of asthma, of these; 
poverty, poor education, under use of self-management,  environmental barriers, low 
public health priority and lack of data on morbidity and mortality from asthma (NHLBI, 
2003).  Other barriers include; the lack of symptoms-based rather than diseased-based 
approaches in management of asthma, unsustainable generalizations across cultures, and 
health care systems which may make management guidelines developed in high-income 
countries difficult to implement in low and middle-income countries (NHLBI, 2003). 
It was chosen to study asthma in ERs as a subject for review and evaluation from various 
aspects: numbers of patients attending the ER with asthma as a percentage of all patients 
attending the ER (Andrrn and Rosenqvist, 1987; Boulet et al., 1996); investigating the 
determinants for attendance of asthmatics at the ER (Wakefield et al., 1997; Eroglu et al., 
2004); managing of asthmatics at the PHC (Peleg et al., 2002; Raimondi et al., 2005); 
evaluating of management protocols of asthma in the ER (Emerman et al., 1999); and the 
utilization of existing health service for assisting the targeting of appropriate future 
intervention in order to reduce avoidable ER attendance (Zeiger et al., 1991; Schatz et al., 
2003).  The asthmatic patients attending the ER are those who deserve our efforts to 
improve their asthma control, so that their quality of life is improved, and asthma related 
morbidity and mortality reduced (NHLBI, 1997). 
1.2 Problem statement and study justification 
Asthma has been considered as an important chronic disease.  International and national 
guidelines have been established in the last decade to manage and control asthma (NHLBI, 
1997; GINA, 2002; Abdeen et al., 2003 ).  The reduction in the acute use of health services 
for asthma was and is still an important goal of asthma management guidelines and 
remains a target of health policy (NHLBI, 2003). Asthma attacks remain a frequent cause 
of attendance and presentations to ERs (Adams et al., 1997). Asthmatic patients attending 
the ERs account for disproportionate amounts of asthma costs, yet these may be minimized 
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or even prevented if patients with asthma and their healthcare providers managed the 
disease according to established guidelines (Weiss et al., 1992; Weiss et al., 1993). 
Studies have shown that 62% of children and 40% of adults reappear for ER care within 
one year (Wakefield et al., 1997), others have indicated that most of ER visits for 
asthmatics could be prevented if patients with asthma and their health care providers 
managed the disease according to established guidelines (NHLBI, 1997; Dales et al., 1997; 
Lara et al., 2002). This attendance was found to be affected by the social, economic, and 
psychological factors (Dianne et al., 2004). 
Emergency visits are important events for asthmatics and families and are associated with 
significant morbidity and occasional mortality (Boulet et al., 1999), and remain a major 
source of substantial asthma-related costs (Weiss et al., 1992; Weiss et al., 1993; Sullivan 
et al., 1996).  Asthmatic patients attending the ERs account for disproportionate amounts 
of these costs, yet these may be minimized by good and optimal asthma management 
(Weiss et al., 1992; Weiss et al., 1993). For these reasons; the assessment and treatment of 
acute asthma has been the focus of considerable research and efforts to develop clinical 
practice guidelines and an interventions programs (Boulet et al., 1999). 
As asthma patients, especially the most sever and chronic cases, are seeking care at 
emergency rooms, so we found them a proper target population for the intended 
intervention program (Joseph et al., 1999). And those seeking emergency care for asthma 
provide a particular target for interventions to improve medical care, as inadequate primary 
care may be one of the causes of poorly controlled asthma (Joseph et al., 199; Montealegre 
et al., 2002). A simple proper intervention program was shown to be effective in reducing 
the ER attendance and better management and control of asthma (Peleg et al., 2002; Ady et 
al., 2003). However, effective management and the extent to which intervention program 
should be applied to control asthma and prevent ER attendance and re-attendance will 
depend primarily on understanding why this occur (Dales et al., 1995).    
An international audit was initiated at the International Union Against Tuberculosis and 
Lung Diseases (IUATLD) (IUATLD, 2003) in year 2003 meeting.  The aim of the audit 
was to develop, a devise and to assess an audit tool for use in emergency rooms that will 
inform the local health services on the need for improving asthma management which 
should identify the targets for improvement.  Palestine was registered as a center in this 
international study (GASP: Global Survey of Asthma Practice). The pilot study in which 
we piloted  56 patients visited ER of Ramallah hospital, with age range 3-85 years, we 
found that 3 (5%) had intermittent asthma and 53 (95%) had persistent asthma, of those 
with persistent asthma 17 (32%) were mild, 30 (57%) were moderate, and only 6 (11%) 
were having severe persistent asthma. Of patients with persistent asthma ; 24 (45%) only 
had regular care, 44 (83%) were insured ones, 52 (98%) were having prescribed steroids, 
and only 26 (49%) reported good compliance to their asthma medications, of those who 
had prescribed steroids 43 (81%) had an adequate dose. This preliminary study showed the 
lack of health care characteristic of those patients, in that only 45% had regular care and 
those are mainly the insured ones, also only 49% reported good compliance to their asthma 
medications, while only 11% were having severe asthma suggesting that disease severity 
could not be always considered as the only risk factor for ER attendance of asthmatics 
(El_Sharif N, September 2004, private communication; Burney et al., 2004, Unpublished). 
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The attendance of asthmatic patients at the ERs with different levels of severity and the 
risk factors for this attendance are still a widespread problem in most countries despite the 
available effective international and national guidelines (Dianne et al., 2004). In order to 
assess the extent of the problem it would be necessary to undertake a study in the ER that 
investigate the risk factors that lead to re-attendance of the asthmatics at the ERs.  
In Palestine, the extent of this problem is not well-known.   In order to develop a proper 
intervention study, we selected Alia governmental hospital ER, as it serves the population 
in the most populated district of the West Bank; i.e. Hebron district. This will give us the 
opportunity to have patients from a various socio-economic backgrounds and geographic 
areas. This study is based on the principles guiding development of complex interventions.  
Therefore, the aim of the present study was to determine the risk factors for frequent 
attendance at ER of Alia governmental hospital in order to set an intervention program for 
proper asthma management and reduce avoidable ER attendance. 
1.3 Aim of the study 
To determine the risk factors for frequent attendance of asthma patients at  ER of Alia 
governmental hospital in order to set an educational intervention program for proper 
asthma management and reduce avoidable ER attendance. 
1.4 Objectives of the study 
1.4.1  General objectives: 
1. To investigate the determinants for frequent attendance and asthma severity of asthma 
patients attending ER of Alia hospital. 
2. To evaluate the reported utilization of health services, quality of care, and medications 
by asthmatic patients attending ER of Alia hospital. 
2.4.2 Specific objectives: 
1. To assess the relationship between frequent ER attendance and asthma severity for 
asthma patients attending ER of Alia hospital. 
2. To determine the relationship between socio-demographic variables of asthma patients 
attending ER of Alia hospital and both their frequent ER attendance and asthma 
severity. 
3. To identify the relationship between health services utilization of asthma patients and 
both their frequent ER attendance and asthma severity at ER of Alia hospital. 
4. To evaluate the relationship between asthma medications intake for asthma patients 
and both their frequent ER attendance and asthma severity at ER of Alia hospital. 
5. To investigate the treatment adequacy of persistent asthmatics by inhaled 
beclomethasone for asthma patients attending ER of Alia hospital. 
6. To recommend an appropriate future educational intervention program that might 
enhance asthma management and reduce avoidable ERs attendance for asthmatics in 
Palestine. 
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1.5  Research questions 
1. Why asthma patients recurrently seek emergency care for asthma despite available 
effective treatment?  
2. Where are we from the considerable international efforts to manage and reduce ER 
related morbidity and mortality of asthma? 
1.6 Study hypotheses 
This study was designed to test the hypotheses that;  
1. The more asthma is severe the more asthma patient attend ERs. 
2. The bad quality of healthcare the more asthma patients attend ERs. 
3. Under treatment by inhaled steroids (beclomethasone) increased the number of sever 
asthmatics to attend ER. 
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1.7 Thesis chapter's description 
This thesis consists of six chapters:
Chapter 1: it deals with the study background, significance, aim, objectives, hypotheses 
and limitations. Further at the end of this chapter, we described the health services and 
demography of Hebron district and West Bank in general. We focused on Alia 
governmental hospital and its emergency department as the study setting.  
Chapter 2: review for literature and previous studies' findings that are related to the 
determinants for ER attendance, asthma morbidity, and the possible interventions to reduce 
this. 
Chapter 3: Conceptual frame work, including asthma definition, its natural history. 
However, asthma chronic and acute classifications were prescribed and management of 
acute attack in ER was also highlighted according to GINA 2002 guidelines (GINA, 2002).  
Chapter 4: Describes the methodology followed, including study design, sample size, data 
collection and analysis. 
Chapter 5: Presents the main results. The result were mainly divided into three parts, i.e. 
socio-demographic, health services provided for asthma patients at the health care system, 
and medications intake. Variables statistical differences between the study outcomes (one-
time vs. frequent ER attendees and mild vs. moderate/severe asthma) were calculated using 
Chi-square in univariate analysis. However, in multivariate analysis, two logistic 
regression models were developed, i.e. one for ER attendance frequency, and the second 
for asthma severity. Adjusted odds ratios with their 95% confidence intervals were 
estimated in each model. 
Chapter 6:  Discuses the main study results including socio-demographic, health services 
utilization, and medications intake. The consistency and contradictory of the study results 
with previous studies are discussed. At the end of the chapter, the main conclusions, 
recommendations, and area for future research are stated. 
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1.8 Demography of Hebron District 
1.8.1 Demographic trends: 
Palestine comprises two separated geographic areas; i.e. the West Bank and the Gaza Strip. 
The West Bank is divided into 9 districts (see map) of which Hebron district is considered 
the biggest southern district.  The population in Palestine is estimated 3.7 million at the end 
of 2003, out of them 2.3 million (63.3%) in West Bank and 1.4 million (36.7%) in Gaza 
Strip (MOH, 2005).  
Hebron district is located among hills in the southern part of the West Bank, 36 kilometres 
(Km) south of Jerusalem city. It was built 5500 BC. There are 153 Palestinian built up 
areas in the district including two refugee camps, Al Fawwar and Al Aroub camps. 
According to the distribution of the population by Governorates, Hebron governorate has 
the highest rate of population of the total population in 2003. The population of the 
governorate is 546.495 according to the Palestinian s 2004 estimates. This population is 
distributed among cities (65%), villages (32.2%) and refugee camps (2.8%).The population 
density of Hebron district is 522 individuals/ km2 (51.1% males and 48.9% females).   The 
district population is considered a young population since 50% is less than 15 years of age 
while the above 65 years represents 2.9 %( MOH, 2005).  
The illiteracy percent in Hebron is 10.1% among males (13.9% in West Bank) and 22.9% 
among females (7.7% in West Bank). Life expectancy in the West Bank was 71.2 years for 
males and 74.3 years for females in 2003. The improved health situation and the gradual 
decline in the infant and child mortality rate contributed to longer life expectancy (MOH, 
2005). 
1.8.2 Mortality trends: 
In 2003, the 10 leading causes of death in Palestine were (in rank order) heart diseases 
(20.1%), cerebrovascular disease (11.1%), conditions in perinatal period (9.7%), malignant 
neoplasm (9%), accidents (8.8%), senility (5.7%), hypertension (4.9%), pneumonia and 
other respiratory disorders (4.8%), diabetes mellitus (4.1%) and renal failure (3.4%). In 
2003, these diseases are responsible for 81.6% of the total deaths in Palestine (MOH, 
2005). In the West Bank, 41 male and 32 female died of pulmonary heart disease of all 
age in 2002. Moreover, 234 male and 144 female died due to respiratory system disease in 
2002, including acute upper and lower respiratory infection, influenza, pneumonia, chronic 
lower respiratory disease (Palestine, MOH, 2003).   
However, in Hebron district the leading causes of death, according to the Palestinian 
Ministry of Health statistics 2003, are heart diseases, accidents, neoplasm, and the 
cardiovascular diseases (MOH, 2005).  The Infant mortality rate in Hebron was 20/1000 in 
2003, and the main leading causes of these deaths are prematurely (40%), congenital 
malformation (10%), respiratory diseases (8%), infectious diseases (8%), and the sudden 
infant death syndrome (SIDS) (4.9%) (MOH, 2005).    
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1.8.3 Socio-economic status: 
The economy of the Hebron revolves around farming and agriculture (particularly the 
cultivation of grapes). Tourism and industries like the manufacture of leather, shoes, 
pottery and glassware also play a rule in its economy. The town has large and busy central. 
Labor indicators in Hebron showed that; 5.7% are job owners, 67.7% are employed, 18.3% 
works in private sector, and 8.3% are members of families without salaries. Those inside 
labor force are 46%, outside labor force are 53.7% (MOH, 2005). 
In 2003 in Palestine, the gross national production (GNP) was 3,705 million US$, while 
per capita it was 1,020 US$. The gross domestic production (GDP) was 3,257 million US$ 
in 2003, while per capita it was 896 US$ (MOH, 2005). The dependency ratio in West 
Bank is high (declined from 94.7 in 1997 to 91.3 in 2003). In 2003, the Palestinian 
National Authority reported that the unemployment rate reached 31% in Palestine with 
constant fluctuation during the last five years due to political situation, and the 
occupation s practices including closure of Palestinian regions and cities (MOH, 2005).  
1.8.4 Health services:  
The Palestinian Ministry of Health (PMOH) is the main health provider in Palestine, 
which is responsible of supervision, regulation, licensure and control for whole health 
services. Other health providers include; the United Nations Relief and Works Agency 
(UNRWA), Medical Services for Police and general security (MSP), national and 
international Non- Governmental Organizations (NGOs), and private health sector for 
profit (MOH, 2005). 
1.8.4.1 Primary health care services:  
Over the past years, the Palestinian health care system has developed side by side along 
with the development of Palestinian society in general.  The total number of PHC centers 
in Palestine in 2003 was 619 (103 in Gaza Strip and 516 in West bank). Distribution by 
provider showed that there were 391 centers owned and supervised by the Palestinian 
ministry of health (63.2%), 51 centers by UNRWA (8.2%) and NGOs have 177 centers 
(28.6%) (MOH, 2005).   
In Palestine the PHC centres per 10,000 population is 1.7 (MOH, 2005).  In the West 
Bank, the ratio of persons per center is 4,09; with the highest ratio in Bethlehem 6,0 
persons per centre and the lowest ratio in Jericho with a ratio of 1,68 persons per center. 
These results should be taken with caution, especially in relation to wide areas and 
scattered population in West Bank (MOH, 2005). 
In Hebron there were 158 PHC centers and the ratio of persons per centre was 18146 in 
2003. The Palestinian ministry of health owned and operated 111 (73 village health room, 
31 maternal and child health clinic and 7 as general clinics), while NGOs 40 and 7 by the 
UNRWA (Palestine, MOH, 2003). 
1.8.4.2 Secondary health care services: 
The secondary health care system is a mixture of a public, non-governmental, UNRWA 
and private sectors with a developing governmental insurance. MOH is responsible for a 
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significant portion of the secondary healthcare system and some of the tertiary care. In 
Palestine, there were 78 hospitals with 4,679 beds in 2003. The ratio of persons per 
hospital was 47,921 while the ratio of beds per 10,000 populations was 12.52 (MOH, 
2005). In Hebron district there are 9 hospitals, with hospital and beds ratio per 100,000 
populations 9.1% and 1.7%; respectively (MOH, 2005). Table (1.1) below shows the 
hospitals in Hebron district by specialty, sector and total beds, in 2002. 
Table 1.1: Hospitals in Hebron district by specialty, sector and total beds, in 2002. 
Hospital   Sector  No. of beds Speciality  
Hebron (Alia ) MOH 147 general  
AL Ahli NGO 103 general 
AL-Meizan NGO 60 general  
Red crescent NGO 60 general  
Yatta  private 12 maternity 
Za tari private 12 maternity 
Shaherah  private 10 maternity  
Hamdan private 10 maternity  
Mohammad Ali Muhtaseb* NGO 30 paediatrics  
Source: Palestinian s MOH report 2002 (Palestine, MOH, 2003). 
* Added by the researcher as it was not found in MOH report 2002. 
The total hospitalization days in MOH hospitals were 683,348 days in 2003 with an 
increasing of 42.6% in comparison with 2000. The total number of admissions was 
255,811 in 2003 which increased by 41% in comparison with 2000. However, the bed 
occupancy rate was 82.4%, and the average length of stay was 2.7 days in 2003. This 
increase in the governmental hospitals' services indicates the impacts of the current 
political situation on all health sectors in general and on hospitals in particular (MOH, 
2005).  
The MOH hospitals provide services for non-admitted patients through their outpatient 
department, emergency departments (EDs), and day care units. The total number of 
beneficiaries from outpatient consultations was 1,286,530, nearly 61.4% of consultations 
were offered through MOH hospitals in Gaza Strip and 23.2 % in West Bank through both 
specialized and general practice clinics in 2002. In year 2003, the emergency departments 
in MOH hospitals received 849,357 care beneficiaries; the number is steadily increased 
since 1999 due to emergency conditions during Al Aqsa Intifada (Palestine, MOH, 2003). 
The day care beds cover a large area of services; including hemodialysis, chronic 
ambulatory peritoneal dialysis, oncology and blood diseases (Palestine, MOH, 2003). 
1.8.4.3 Human resources: 
The population per general practitioner in Palestine was 2011 in 2003 estimates. However, 
in MOH the population per physician, specialist, and nurse was 2171, 5613, and 1394; 
respectively (MOH, 2005). In Hebron district, the population per MOH general practitioner 
was 1477, while per nurse was 781. However,  per paramedical the population was 93 
(MOH, 2005). Further, in Hebron there are two governmental PHC centers for chest and 
allergy diseases the major one is located in Hebron city while the other in Dora city.    
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1.8.4.4 Governmental health insurance (GHI): 
In Palestine, MOH provided free of charge health insurance to about 189,934 family in 
2001, to 207,434 in 2002, and to 95,449 in 2003 (MOH, 2005). The enrolment in GHI 
grew from 50 % in 1998, to 53.2% in 1999. However, it declined to 34% in 2000, 31% in 
2001, 34.6% in 2002 and 38.6% in 2003 of the total West Bank and Gaza Strip population. 
The decrease in enrollment in GHI since 2000 was due to the impact of current crisis (AL 
Aqsa Intifada ) on Palestinian community (MOH, 2005). During ALAqsa Intifada most of 
the Palestinian s workers who used to work in Israel and lost their work got benefit from 
Al-Aqsa insurance which was established after Al- Aqsa Intifada. In Hebron district, 70% 
of the population has GHI (Head of health insurance department-Hebron, October 2005, 
private communication). 
Every Palestinian with a governmental health insurance can get treatment, vaccination, 
surgical operation, and the other health services in any of the ministry of health hospitals, 
centers and clinics (general and specialized) on free of charge, but for each medication 
bottle or box he/she has to pay three Shekels if he/she is more than 3 years old, and one 
Shekel if he/she is less than 3 years (Head of health insurance department-Hebron, October 
2005, Private communication). Insured patients can also get benefit from treatment abroad 
(out side Palestine) if his/her treatment and the required health are not found in Palestine. 
Types of participation in the GHI include (MOH, 2005);  
1. Compulsory: the families' participation from this group was about 28.2% of the total 
insurance Participation in 2003. It constituted 56.6% of the total governmental 
insurance revenues in 2003. 
2. Voluntary: since the year 1995, there was a gradual decline in the number of insured 
families in the voluntary type. This was due to deterioration in Palestinian economy. It 
constituted 2% of the total governmental insurance revenues in 2003. 
3. Workers in Israel: this group showed the highest decline in the percentage of its 
revenues from 40.6% in 1995 to 9.8% in 2003. This was mainly affected by the 
Israeli's closures and ALAqsa Intifada. 
4. Contracts: this group represented 5.6% of the total participants in 2003. The revenue 
collected from this group was 11.3% in 2003. 
5. Social welfare: this group represented 19.2% of the total participants in 2003. The 
Ministry of Social Welfare paid 19.5% in 2003 of the total insurance revenue. 
6. Prisoners affairs: this group represented 0.6% of the total participants in 2003, and the 
revenue was about 0.8% of the total insurance revenue.       
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1.8.4.5 Alia governmental hospital in Hebron: 
Alia hospital was built in 1959, it is a general governmental hospital located in Faisal 
Street in the middle of Hebron city in the southern part of the West Bank (Fig.1.1). 
Figure 1.1: Entrance of Alia hospital. 
The hospital includes two buildings which are; the central (middle) building: it includes the 
following departments (surgical department, internal department, intensive care unit (ICU), 
coronary care unit (CCU), pre-mature unit, maternity department, theatre room sterilization 
unit, laboratory and blood bank, radiation unit, pharmacy and medical stores,  
physiotherapy unit, and the adult emergency department; i.e. >14 years old).  The out-
patient clinics: include surgery, bone, internal, ENT (Ear Nose and Throat), pediatric, and 
maternity clinics.  The western building: it includes the following departments ( kidney 
unit, central maintenance unit,  pediatric departments including the pediatric emergency 
department; i.e.  14 years old) (Fig. 1.2) (Alia hospital management supervisor, 
November 2005, private communication). 
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Figure 1.2: Alia hospital pediatric emergency room. 
The adult s emergency department of Alia hospital consists of three rooms with 6 beds. 
The main room; which has three beds, and a surface area of 30 m2 (meter square), it is 
where the emergency cases are treated and it includes the main required machines like 
monitors, defibrillator, nebulizers, it has also the essential emergency drugs. It receives 
cases of nearly all disorders including the asthmatic cases (Fig.1.3). But most of those 
attend Alia emergency department are insured ones and they pay only 3 Shekels for each 
treatment unit (injection, nebulizer, other medications) and 2 Shekels for each X-ray (Alia 
hospital management supervisor, November 2005, private communication). 
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Figure 1.3: Photos from the Alia hospital first adult's emergency room.  
The second room; surface area 24 m2 (meter square) , has two beds, it is where treated 
emergency cases are put under observation and wait until they recover so they will be 
discharged home. It includes also the emergency registration (Fig. 1.4) (Alia hospital 
management supervisor, November 2005, private communication). 
Figure 1.4: Photos from Alia hospital second adult's emergency room.  
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The third room;  surface area 12 m2, and has one bed. It  receives  fracture cases. Alia 
emergency department receive an average of 200 cases each day, 100-150 are urgent and 
emergency cases, 40 are wounded and post-operation cases, 5-10 are fracture cases (Fig. 
1.5) (Alia hospital management supervisor, November 2005, private communication). 
Figure 1.5: Emergency cases attending Alia hospital emergency departments. 
With the 6 beds in the adult emergency department, this gives a total of 147 beds in Alia 
hospital and 8 beds for hemodialysis in kidney unit (Alia hospital management supervisor, 
November 2005, private communication). Approximately, 70% of the population in 
Hebron district have medical insurance and usually seek medical care in this hospital. Alia 
governmental hospital has the major ER in Hebron district.  Therefore, we assume that 
patients from various socioeconomic, demography and communities (urban, suburban, and 
rural ) have access to this hospital. (Head of health insurance department-Hebron, October 
2005, Private communication).  
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Chapter 2 
Literature review  
2.1 Introduction  
Asthma in ERs was started to be of great interest in the past decade.   Several studies in 
Australia (Wakefield et al., 1997; Robertson et al., 1998), United States (Weiss et al., 
1992; Mannino et al., 2002), Europe (Cerveri et al., 1997; Jansen et al., 1997), Canada 
(Krahn et al., 1996) and other Middle Eastern countries (Goren and Hellmann, 1997; EL 
Sharif, 2003), such as Saudi Arabia (AL Frayh et al., 2001), were concerned with asthma 
morbidity and mortality.  
The importance of studying asthma in ERs is that patients with asthma appearing in ERs 
are those who have sub-optimal treatment and those depending on the local management of 
patients in the community (Anis et al., 2001; Rabe et al., 2004). To get around this problem 
these studies  proposed a method to assess the extent of the local problem through the cases 
coming through the local ERs, so as they can devise and assess a tool for use in emergency 
rooms that will inform the local health services on the need for improving asthma 
management and identify the targets for improvement. 
The major health effort in ameliorating the severity of asthma, preventing exacerbations or 
attacks, and reducing the risk of death or permanent disability is clinical management. The 
availability of well-trained staff, adequate medications, and the presence of self-
management and monitoring tools will make asthma a straightforward manageable 
disorder (NSW Department of Health, 1997). 
2.2 Determinants for ER attendance 
The determinants for the attendance of asthmatic patients at the ERs and the possible 
effective interventions are one of the most observed public health problems in the world 
today. By detecting those attended the ERs for asthma and related specific risk factors, we 
can ensure a good management and intervention programs for an appropriate managed 
asthma (Ait-Khaled et al., 2001; Ford et al., 2001; Douglass et al., 2004). 
Risk factors found in literature that contribute to ER attendance for asthmatic patients 
usually include one or more of the followings reasons:  
2.2.1  Poor doctor-patient relationship: 
Poor therapeutic partnership between patient and his doctor has been indicated as 
inadequate health services that lead to ER visits for asthma. Individuals attending to ER for 
asthma don t have a good doctor-patient relationship or may not even have a doctor for 
asthma care (Marks et al., 2003). A study found that (Douglass et al., 2004) of 62 
asthmatic patients attending the ER, 2/3 reported a good relationship with their doctor, 
one-third reported a poor relationship or no regular doctor.  
Another study concluded that doctors need to explore and acknowledge their patients 
personal disease experience and opinions and to respect a patients interpretation of their 
symptoms (Clark and Gong, 2000). It was also found that ER visits for asthma are 
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associated with lack of access to regular medical care (Oster and Bindman, 2003) and 
several studies indicated that increase access to primary health care results in fewer ER 
visits and hospitalizations for asthma (Greinder et al., 1995; Stewart et al., 1999; Falik et 
al., 2001). 
2.2.2  Health insurance: 
Studies demonstrated that uninsured patients have higher rates of preventable ER visits 
because they are less likely to have follow up and regular medical care (Oster and 
Bindman, 2003). Other studies in USA found that of 3612 patients attending the ERs for 
asthma, 96.3% were insured ones (Ponda et al., February 2005), while a recent study in 
Argentina indicated no health insurance coverage was available to 75.5% of asthmatic 
patients attending the ERs (Raimondi et al., 2005). It was also reported that only 56% were 
covered by medical insurance of those attending the ER for asthma (Eroglu G, Tugaeon A 
et al., 2004). In Ramallah, in year 2002 a study of 56 asthmatic patients attending the ER 
for acute asthma attack, 83% reported to have health insurance (El_Sharif N, September 
2004, private communication).  
2.2.3  Lack of specialty care:  
Lack of access to specialist care for asthma may be a common risk factor for ER 
attendance and re-attendance (Dianne et al., 2004). Studies have indicated that general 
practitioners underestimate the severity of asthma and as a result preventive therapy is 
underused (Gellert et al., 1990). 
A number of cohort studies have suggested that allergy specialist care reduces asthma ER 
visits and hospitalizations or both (Zeiger et al., 1991;  Zeiger and Schatz, 2000). The 
studies indicated that those with allergy or pulmonary specialty care received more 
dispensations of inhaled corticosteroids per year than those without such care. They 
concluded that allergy or pulmonary care provide patients with education, environmental 
control, use of other medications which contribute to reduced ER visits (Schatz et al., 
2003;  Allen-Ramey et al., 2004). Moreover, those attending ER for having their regular 
care, have an opportunity to introduce inhaled corticosteroids to their therapy since they 
don t have an established source of primary health care (Singh A, Woodruff P et al., 1999). 
In a study in Turkey, 2004 (Eroglu G, Sulun F et al., February 2004 ), of 151 ER attended 
pediatric asthmatic patients, asthma specialist followed only 25, while 50 were followed by 
pediatricians or primary health physician, and the remaining half were used ER as their 
routine care. Other study in Argentina found that 26% of ER attended asthmatic patients 
use ER as their routine care (Raimondi et al., 2005). Thus lack of access to asthma 
specialty care may be a significant risk factor for ER attendance and under treatment of 
asthma as well as failure to have a regular follow up care (Dianne et al., 2004). 
2.2.4  Under-use of anti-inflammatory and overuse of B2-agonists: 
Inhaled corticosteroids are the only treatment for asthma that has consistently been shown 
to reduce the morbidity and mortality of asthma (Suissa and Ernst, 2001). However, many 
studies have reported under treatment by inhaled corticosteroids and over use of inhaled 
B2-agonists which cause a worsening of asthma control leading to increased risk of ER 
visits (Taylor et al., 1990; Anis et al., 2001). 
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The use of inhaled corticosteroids in some studies for patients attending the ER was 
reported to range from 20-26 %, whereas according to GINA it should be 100% (Dales et 
al., 1995;  Rabe et al., 2000; Bergquist and Crompton, 2001). 
Over reliance on B2-agonists was reported to be high compared to inhaled corticosteroids 
in patients attending the ER. One study in USA, showed that (Eroglu G, Tugaeon A et al., 
2004), 63% of patients just relied on B2-agonists, while only 24% reported using inhaled 
corticosteroids.  This study concluded that marked under use of anti-inflammatory drugs 
are important risk factor for ER attendance and repeat attendance and there is a need to 
institute aggressive interventions to improve the quality of care for asthma. 
A large scale international survey found that the use of anti-inflammatory medication even 
in patients with severe persistent asthma was low, ranging from 26% in Western Europe, to 
9% in Japan, and there was a significant increase in the use of quick relief over preventive 
medication in all countries (Rabe et al., 2004). Although this study was not carried out in 
ERs, it reflects the suboptimal management of asthma worldwide that lead at the end to 
increased ER attendance for asthma. Meanwhile, it is consistent with other studies carried 
in the ERs (Spitzer et al., 1992; Dales et al., 1995; Kolbe et al., 1997). 
In a study carried out in Turkey in 2004, only 51.7% of 151 pediatric asthmatic patients 
attending the ER for asthma were treated with inhaled anti-inflammatory despite their 
moderate to severe asthma, while the other majority was relied on inhaled B2-agonists also 
despite their moderate to severe asthma (Eroglu G, Sulun F et al., February 2004 ). 
Another multinational study by Burney et al. 2004 (Burney et al., 2004, Unpublished) 
found that only 36% of 1062 patients of asthma in the ERs with persistent asthma had been 
prescribed an adequate dose of steroids according to GINA guidelines (GINA, 2002) and 
those are mainly with regular healthcare and insured ones. 
2.2.5  Poor self-management and absence of asthma action plan: 
Under treatment doesn t explain all cases of frequent ER attendance for asthma. It was 
found that patients with frequent ER visits showed significantly lesser knowledge of 
asthma control criteria, as well as over all trend toward reduced asthma management 
knowledge and skills (Boulet et al., 1996). Other studies found that the lack of proper use 
of inhalers was related to ER attendance, the lack of asthma knowledge is a modifiable 
reason for ER attendance and repeat attendance and that psychological factors like 
avoidance coping and attitudes to self-management were also related to acute use of health 
services for asthma (Peleg et al., 2002; Dianne et al., 2004).  
Studies indicated that, optimal self-management including a written asthma plan and 
regular medical review led to a reduced number of ER visits (Gibson, 2000; Sulaimana et 
al., 2004). A study carried out in USA, found that only 48%of those attended the ER for 
asthma had an action plan (Kelly et al., 2004). Another study in Argentina reported that 
43% had been provided by management plan by their physicians (Raimondi et al., 2005). 
Studies showed that, the reasons for those not possessing a plan for asthma were they had 
not been given it by their doctors (Douglass et al., 2002). 
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2.2.6  Previous ER visits and hospitalization: 
Many studies indicated an association between current ER attendance and the presence of 
previous ER visits or hospitalization. A study in USA found that out of 1027 patients, 27% 
reported five or more ER visits in the past year (Kelly et al., 2004). Another study  in USA  
reported that about 60% visited the ER (1-4) times, 30% (5-9) times, 7% (10-14) times and 
3% (15-19) times in the past year (Eroglu G, Tugaeon A et al., 2004). A study  in the ER 
for asthma in Australia  found that 58% of asthmatics attending the ER were hospitalized 
(3-5) times in previous year (Dianne et al., 2002). 
The 8 weeks period studies in the ERs in USA, showed that having 3 or more visits to ER 
within previous 3 months is a significant predictors of ER relapse (Newcomb and Akhter, 
1986; Emerman and Cydulka, 1995; Ducharme and Kramer, 1996; Carren, 1998; ). The 
researchers examined 293 patients with moderate to severe asthma attending the ER, found 
that 16% had two or more hospital admissions and 32% had two or more visits to ER in the 
past year (Adams et al., 2000). 
2.2.7  Therapeutic non-adherence:  
One of the major problems in asthmatic patients attending the ERs is compliance 
(Milgrom et al., 1996). Studies showed that as many as one half of asthma patients fail to 
adhere to daily treatment regimens either intentionally, unintentionally, or unknowingly 
(Sherman et al., 2000). Yet, long term adherence to appropriate medications is the 
necessary link between effective asthma therapy and well controlled asthma (Dianne et al., 
2002). Studies showed that even with optimal patient follow up, adherence to prophylactic 
treatment was only 77% (Jonasson et al., 1999).  
Reasons for non-compliance to medications including; poor understanding, fear of steroids 
side effects, adolescence, low socio-economic status, and psychological factors as a wish 
to be just like every one else (Balfour, 1999; Sherman et al., 2000). A study in ER in 
Australia in year 2000, found that medication cost was of concern to nearly 63% of the 
patients and 70% had co-morbidities and require multiple medications, thus they either 
didn t buy or lowering the doses of their medications to prolong their use (Dianne et al., 
2002).  Burney et al. 2004 indicated that 74% of those have health insurance covered some 
of their asthma medications, reported good compliance with treatment compared to 
uninsured patients ( Burney et al., 2004, Unpublished). In Ramallah ER pilot survey, of 56 
patients only 49% reported to be adherent to treatment (El_Sharif N, September 2004, 
private communication). 
2.2.8  Low socio-economic status: 
The gap in asthma care outcomes and ER visits associated with socio-economic disparities 
was reported by many studies (Kolbe et al., 1997; Apter et al., 1998; Lara et al., 1999). 
Studies found that socio-economic indicators such as not finishing high school, being a 
member of a minority ethnic (Apter et al., 1998) or a single-parent family (Kolbe et al., 
1997) have all been independently associated with asthma ER attendance and poor 
medication adherence. Low socio-economic status are usually associated with greater 
exposure to causes and trigger factors arising from poor housing or financial barriers to 
quality of health services and medications for asthma (Dianne et al., 2002). Studies also 
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showed that women were on greater risk for ER attendance for asthma, and in one study 
they were in a ratio of nearly 2:1 (Singh A, Cydulka R et al., 1999; Douglass et al., 2002). 
2.2.9  Asthma severity:  
Severe chronic asthma was shown to be associated with ER attendance for asthmatics. In 
Australia, a study found that of 62 patients attended the ER, 2/3 had severe chronic asthma, 
and patients reporting for their current attendance to ER was, 59% due to respiratory tract 
infection, 19% due to sudden shortness of breath, other reasons include medication use, 
costs, and concerns. This study concluded that disease severity is one of the risk factors for 
ER attendance for asthmatics (Dianne et al., 2004).  
Another study in Australia  indicated that chronic asthma severity in patients attended the 
ER was, 52% had severe asthma, 23% had moderate, and 26% had mild asthma (Dianne et 
al., 2002). A study in ER in USA, found that of 1027 patients, 67% were persistent 
asthmatics (Kelly et al., 2004), while Burney et al. 2004 indicated that of 1062 patients 
attended the ERs in a multinational study, 78% had persistent asthma, of those; 30% had 
severe persistent asthma, 27% had mild asthma ( Burney et al., 2004, Unpublished). 
2.2.10  Ambient air pollution: 
Ambient air pollution as a risk factor for ER attendance for asthmatics is significantly 
related and mentioned in previous studies (Tob?A et al., 1999; Fauroux et al., 2000; 
Wilson et al., 2005). A time series study in France found a positive statistical association 
between daily asthma ER visits and daily variations of ozone and nitrogen dioxide levels 
after controlling for weekly and monthly variations (Fauroux et al., 2000). Another recent  
study in England (Wilson et al., 2005) also revealed that on daily basis, elevated sulfur 
dioxide and ozone have a significant impact on ER visits for asthma. 
2.3  Summary of ER attendance determinants 
In brief summary, it was found in USA that lack of access to regular medical care, absence 
of health insurance (Oster and Bindman, 2003), lack of specialist care (Zeiger et al., 1991), 
under use of anti-inflammatory and over use of short  B-agonist (Eroglu G, Tugaeon A et 
al., 2004), poor self management (Boulet et al., 1996), absence of action plan for asthma, 
asthma severity (Kelly et al., 2004), and low socio-economic status (Apter et al., 1998) 
were all associated with ER attendance for asthma. However, in Australia no regular 
doctor for asthma care (Douglass et al., 2004), previous hospital admissions, therapeutic 
non adherence, low socio-economic status (Dianne et al., 2002), lack of specialist care for 
asthma, lack of proper use of inhalers and asthma severity (Dianne et al., 2004) were found 
to be related. 
Further, in England it was concluded that doctors should explore and acknowledge their 
patients personal disease and opinions (Clark and Gong, 2000) in order to decrease ER 
attendance. In Turkey, lack of access to specialist care, under treatment by steroids and 
over use of B-agonist (Eroglu G, Sulun F et al., February 2004), were found to be risk 
factors for ER attendance for asthmatics. In Canada, under use of steroids and over reliance 
of reliever therapy was associated (Anis et al., 2001). In Argentina, certain factors were 
found, like no health insurance coverage, depending on ER for asthma care, and absence of 
action plan for asthma (Raimondi et al., 2005). In Western Europe and Japan Rabe et al. 
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(2004) reported under use of anti-inflammatory. Meanwhile, in Israel, Peleg et al. 2002 
reported lack of proper use of inhalers, and general poor self management among 
asthmatics (Peleg et al., 2002). 
In a multinational study, included several countries in the world (England, France, Chile, 
Algeria, Tunisia, Sudan, Kuwait, Palestine, Syria, Bosnia, and Canada) Burney et al. 2004 
reported under treatment and under use of anti-inflammatory among patients attending ER 
for asthma care (Burney et al., 2004, Unpublished). 
2.4  Determinants of asthma morbidity 
Although disease severity and socio-economic factors are well known contributors to 
asthma morbidity (NHLBI, 2003), the influence of personal psycho-social factors play also 
a role (Dales et al., 1995; Kolbe et al., 1997). Other factors include under-diagnosis and 
under-treatment (Woolcock et al., 1989; NHLBI, 1991; GINA, 1995), non-compliance 
with prescribed medical regimens (Birkhead et al., 1989; Brooks et al., 1994; Rand and 
Wise, 1994), inability to use medications properly, especially inhaled medication (Bailey et 
al., 1990; Belda, 1995), under-treatment with anti-inflammatory medication, and overuse 
of beta adrenergic bronchodilators (Woolcock et al., 1989; Spitzer et al., 1992). Other 
factors such as poor understanding of the disease process or lack of disease management 
have been identified as a major problem for patients with asthma (NHLBI, 1991; Dales et 
al., 1995; Kolbe et al., 1997).   
The cost of having medical care could be also considered as one of the determinants of 
asthma morbidity.  Asthma costs are substantial (Weiss et al., 1992) and this relates both to 
treatment costs and the use of health services consequent on poor disease control (Weiss 
and Sullvian, 1993). Asthmatic patients attending the emergency rooms account for 
disproportionate amounts of the costs (Weiss and Sullvian, 1993). 
The economic cost of asthma is considerable both in terms of direct medical costs (such as 
hospital admissions and cost of pharmaceuticals) and indirect medical costs ( such as time 
lost from work and premature deaths) (Weiss et al., 1992; Krahn et al., 1996). In the USA, 
the direct cost of asthma was estimated to be 6.2 billions per year, and the indirect cost 
related to reduced productivity caused by absenteeism at school or work was calculated to 
be 1 billion per year (Weiss et al., 1992).  Moreover, hospital care costs for asthma account 
for nearly 50% of the direct cost spent on this disease (Weiss et al., 1992), and in Canada, 
the cost reached $600 million (Krahn et al., 1996).  In Australia, the direct and indirect 
costs for asthma in 1994 estimates ranged from (US$586-US$718) million/ year (NACA, 
2002). 
Although morbidity and mortality from asthma are significant problems, a substantial 
proportion of the problems caused by asthma could be averted if patients with asthma and 
their health care providers managed the disease according to established guidelines 
(Smaha, 2001).  Implementation of any intervention is also critical for its impact and any 
successful interventions will not only improve quality of life for patients with asthma, but 
also likely produce significance cost savings among health insures (Smaha, 2001).    
 22 
2.5  Interventions to reduce ER attendance 
Studies have shown that interventions that address all or some different aspects of asthma 
care leading to reduction in ER attendance for asthmatics. These aspects include; 
2.5.1  Patients education and self-management: 
In patients making frequent visits to ER, studies showed that, asthma control can possibly 
be improved by patient participation in an asthma education program that addresses the 
deficiencies observed (Jones et al., 1987; Mayo et al., 1990). Other study found that use of 
an action plan for asthma and measurements of PEFR are potential tools for improving 
patients self-management skills and reducing ER attendance (Beasley et al., 1989). It was 
concluded that, an ER based education program for patients, concentrated on patients self-
management of their asthma, providing instructions for proper inhaler technique would 
probably result in decreased numbers of ER visit (Mayo et al., 1990; Bolton et al., 1991; 
Newhouse, 1994; Greineder et al., 1995). Another study showed that, an educational 
program for patients in outpatient clinic contains video cassette, brochure, education 
seminars , proper inhalation device usage, telephone lines helping, produced significant 
improvement in clinical and functional measures of asthma with a reduction in ER usage 
(Marabini et al., 2002; Yilmaz et al., 2002). 
In Israel, an intervention program in PHC clinics in Muslim Bedouin sector in Negav, 
concentrated on patients education including improved hygiene, use of asthma medications 
and equipment, allergens avoidance, and health fair, resulted in reduced referrals to ER 
from 22.8% (61 patients ) to 2.2% (6 patients ) after the program (Peleg et al., 2002). 
In France, a recent study concluded that framing the controller medications use by patients 
and educating families about how to manage the disease and to improve their domestic 
environment, would result in reduced ER visits (Ploin et al., 2005). 
2.5.2  Educating health care professionals:   
An organized disease intervention program for primary care physicians increased 
adherence to asthma management guidelines for anti-inflammatory use. This adherence 
reduced ER visits and hospitalization for asthma. In USA, it was found that after the 
intervention program, anti-inflammatory therapy increased from 38% to 96% and ER visits 
decreased by 27% (Cloutier et al., 2005). 
Despite the fact that, ERs are often busy facilities, they can provide a vital link for the 
patient to other healthcare setting. Studies showed that ER initiated referral is relatively  
low complexity interventions, as discharge instructions care are already a routine part of 
ER discharge care, and such an intervention seems to improve compliance with the 
recommendations of early post-ER primary healthcare utilization or referral (Smaha, 
2001). ER-based physicians education and ER-Feedback, specially for those who use ER 
as their routine source of care and don t have an established PHC to prescribe inhaled 
steroids for them,  would probably result in improved quality of care in the ER and 
decreased ER visits.  
It was found that such a system increased proper use of inhalers from 18% to 60%, 
assessing asthma severity increased from 44% to 95%, a written asthma action plan 
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improved from 50% to 85%, and steroids use from 64% to 81% over a year. (Singh A, 
Woodruff P et al., 1999; Walsh-Kelly et al., 2005). Studies in USA indicated that 
implementation of non-medication aspects of asthma care by physicians and nurses, 
specifically the provision of an action plans, may reduce the ER use for asthmatics 
(Jackson R et al., 1988; Smaha et al., 2001). It was indicated that following the 
recommendations of surveillance and medical follow up care in ERs, would be important 
in any interventions to reduce ER attendance for asthma (Smaha et al., 2001). 
2.5.3  Reducing  economic barriers: 
Exploring the barriers to financing and treatment could further stratify targeted 
interventions in reducing the ER attendance for asthmatics, and would increase patients 
compliance and adherence to prescribed medications, specially in low socio-economic 
status patients (Dianne et al., 2004). 
2.5.4  Evaluation of patients psychosocial factors: 
Andrrn and Rosenqvist  (Andrrn and Rosenqvist, 1987 ) concluded that, psychosocial 
factors related to ER visits for asthma should be evaluated and addressed for future 
interventions to reduce ER attendance. They reported that living alone, perceived 
loneliness were predictive factors for frequent ER visits for asthma, and these factors may 
influence compliance with treatment leading to poor asthma control and increased ER 
visits (Andrrn and Rosenqvist, 1987; Barton et al., 2005).Other studies found that patients 
attitudes and coping styles to using asthma medications, fears of steroids, culture aspects of 
inhalers use, will be important in any interventions to reduce ER visits (Dianne et al., 
2002). 
2.5.5  Recognize asthma as a public health priority:  
Effective interventions to control and reduce ER visits for asthma depend on the 
recognition of asthma as a major public health problem at the national and international 
levels. Also, the requirement of respiratory specialist and related organizations at the 
national level is important for optimal asthma management and reducing ER visit (Dianne 
et al., 2004). Adaptation of asthma international and national guidelines with adequate 
governmental resources for healthcare including asthma is also necessary (GINA, 2002). 
As  with other multidimensional public health problem, asthma effective solutions depend 
on the extent to which policy makers can design and implement multiphased policy 
reforms that go beyond medical care and reach the broader physical and social 
environment in which  asthmatic patients live. Not only the quality and accessibility of 
medical care, but fundamentally, the social determinants of health (GINA, 2002; NHLBI, 
2003).      
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2.6  Summary 
The literature shows that risk factors for frequent ER attendance and asthma severity could 
be either non-preventable (non-modifiable risk factors) which could not be changed and 
preventable (modifiable risk factors)  which could be changed by proper interventions. 
In general, non-preventable risk factors for frequent ER attendance and asthma severity are 
uncountable in comparison to preventable ones. Of these non-preventable are; age, sex 
(female), race, and low socio-economic status in general. Further, for those patients a 
proper education and availability of less constable and proper prescribed  medications 
might decrease their frequent ER attendance and asthma severity and also increase their 
compliance and adherence to prescribed medications. 
However, preventable risk factors are greatly contributing to frequent ER attendance and 
asthma severity. These factors could be changed and result in a good asthma management, 
low or absence of  ER attendance and in a prevention or decrease in asthma severity. Of 
these preventable (modifiable) risk factors are; under-treatment by inhaled anti-
inflammatory, over-use of B2-agonists, poor self-management, absence of action plan, 
therapeutic non-adherence, lack of specialist care, improper use of inhalers, poor 
understanding of the disease process,  poor doctor-patient relationship and bad quality of 
care in general.  Meanwhile, interventions to reduce these modifiable factors include; 
patients education and self-management, educating health care professionals,  
improvement in recording system for asthmatics, proper pharmacotherapy, good doctor-
patient relationship and by enhancement of health care quality and access. 
The literature review shows that ER attendance for asthma is a widespread health problem, 
and mostly a modifiable problem which needs considerable attentions to reduce it to the 
lowest possible level. This can be achieved by continuous efforts of those who appreciate 
the value of mankind. What is clear from above, in spite of the limited resources, that the 
implementation of an intervention program based on principles is needed. What is 
discussed above can result in favorable asthma outcomes in local community. 
However, an ER visit within the past month for asthma, and 3 or more ER visits for asthma 
in the past year, is both risk factors for death from asthma (NHLBI, 1997). Preventing ER 
attendance for asthmatic patients by adequate management and proper healthcare resources 
can possibly prevent this death, and not only produce a healthier people but also improved 
family functioning, workplace productivity, and overall family well being (Ait-Khaled et 
al., 2001). 
For these reasons, future considerable research should concentrate on the assessment and 
treatment of asthma to develop clinical practiced guidelines and interventions programs to 
minimize these factors especially the preventable ones (NHLBI, 1997; Boulet et al., 1999).  
 25 
Chapter 3 
Conceptual framework  
3.1  Definition of asthma 
Working definitions of asthma emerged from two Ciba Foundation symposia in 1959 and 
1971, which stated that asthma was predominantly a disease of airway smooth muscle, 
which was altered so that it contracted too easily and too much (Nadel and Busse, 1998). 
The NHLBI, 1997 (NHLBI, 1997) defined asthma as:   
A chronic inflammatory disorder of the airways in which many cells and cellular elements 
play a role, in particular, mast cells, eosinophils, T-lymphocytes, macrophages, neutrophiles, 
and epithelial cells. In susceptible individuals, this inflammation causes recurrent episodes of 
wheezing, breathlessness, chest tightness, and coughing, particularly at night or in the early 
morning. These episodes are usually associated with widespread but variable airflow 
obstruction that is often reversible either spontaneously or with treatment. The inflammation 
also causes an associated increase in the existing bronchial hyper- responsiveness to a variety 
of stimuli . 
3.2  Natural history of asthma 
Several studies (Platt-Mills et al., 2001; De Marco et al., 2002) showed that, in respect to 
its natural history, asthma presents two different forms;  
1. Early-onset asthma: occurs early in childhood, affects mainly boys, and has a good 
prognosis. 
2. Late-onset asthma: occurs during or after puberty, affects mainly women, and has a 
poor prognosis. 
Airflow obstruction or limitation in asthma is caused by bronchoconstriction, mucous 
plugs, swelling, and increased inflammation. The inflammatory process can cause 
permanent changes in the airways. Long term changes include increased smooth muscle, 
increase in bronchial blood vessels, thickening of collagen layers, and loss of normal 
distensibility of the airway (Corrigan and Kay, 1991). 
The mechanism by which acute episodes are initiated and sustained are for the most part 
unknown (McFadden and Hejal, 2000). However, cell activation with production of potent 
mediators of inflammation is believed to be central to the pathophysiology of asthma. 
Almost all the inflammatory cells present in the bronchial wall and lumen have been 
implicated in the pathogenesis of mucosal inflammation in asthma (Fig.3.1) (Holgate, 
1997). 
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Figure 3.1: Natural history of asthma. Schematic of the natural history of asthma 
demonstrates several possible features of the disease. Adapted from Holgate ST, 1997. 
Many factors have been implicated in the induction and exacerbations of asthma (GINA, 
2002). Remissions and relapses may occur and, in those in whom the asthma disease 
persists, outcomes vary from mild to severe effects on lifestyle with occasional deaths 
attributable. Moreover, there is a latency period from exposure to actual sensitization and it 
can range from months to years (Holgate, 1997).   
This complexity of the natural history of asthma influences the approach to its prevention 
(NSW Department of Health, 1997). The determinants which have been implicated in the 
induction and exacerbations of asthma include; allergy, atopy and/or family history of 
asthma, respiratory (viral) infections, occupational, socio-economic, environmental (indoor 
and outdoor pollution), weather changes, exercise, psychological, and some drugs (GINA, 
2002). Atopy is the foremost predisposing factor for the development of asthma (Holgate, 
1997; De Marco et al., 2002).  Allergic asthma occurs when individuals become sensitized 
to allergens such as animals dander, grass pollens, tree pollens, house dust mites, and flour 
or grain dust (Corrigan and Key, 1991).  For instance, Environmental tobacco smoke 
(ETS) can induce and exacerbate asthma (Holgate, 1997).  Therefore, infants with a family 
history or atopy, have to be avoided from exposure to passive smoking, domestic dust 
mite, cat, and cockroach allergens that might help preventing the initial development of 
asthma. For adults, avoiding exposure to smoke and to chemical sensitizers in the 
workplace might be helpful in avoiding the appearance or exacerbation of asthma and its 
symptoms (NHLBI, 2003; Australia, NACA, 2002). Occupational exposures can induce 
asthma in a previously healthy person, whereas non-allergic type environmental agents 
such as ozone (O3) and sulfur dioxide (SO2) can exacerbate pre-existing asthma (NHLBI, 
2003).  
3.3  Asthma medications 
There are separate types of medications for the management of asthma, and usually in 
different pharmaceutical forms range from tablets, SR-tablets (Sustained-release), syrups, 
inhalers, nebulizers, and parenteral. These medications are divided into three basic types  
and usually recommended by severity level and age (Katzung et al., 1997; Australia, 
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NACA, 2002; GINA, 2002): (1) Type 1, controller ( Preventer or Anti-inflammatory) 
which is a medication that keeps symptoms and attack from starting. They include; 
steroids, Na+-cromoglycate, nedocromil, long acting B2-agonists, SR-theophyline 
(Sustained-release), and anti-leukotrienes; (2) Type 2: Reliever ( Bronchodilator) which  
works quickly to treat attacks or relief symptoms. They include; short acting B2-agonists, 
anti-cholinergic, short acting theophyline, and adrenaline injection; (3) Other Medications 
include antibiotic for respiratory infections, anti-histamines for treatment allergy 
symptoms, and complementary medicines which are plant or herbal products, but should 
be used with caution and care to ensure safety and efficacy.  
3.4  Classification of chronic asthma severity 
There are different guidelines for classification of asthma severity. But they usually follow 
the American NAEPP guidelines, 1997 (NHLBI, 1997), or GINA guidelines, 2002 (GINA, 
2002), or the Australian guidelines, 2002 (Australia, NACA, 2002). The NAEPP and 
GINA guidelines use four basic levels of severity (mild intermittent, mild persistent, 
moderate persistent and severe persistent) and their classification usually based on 
day/night time symptoms, physical activity, and FEV1 (% predicted). The NAEPP and 
GINA guidelines are nearly close to each other. However,  the Australian guidelines use 
only three basic levels of severity (mild, moderate, and severe asthma) and their 
classification usually based on day/night time symptoms, FEV1 (% predicted), previous 
ER attendance and hospital admissions in past year, and frequency use of bronchodilator. 
The GINA 2002 guidelines classify asthma into four levels of severity in which the 
presence of one of the features of severity is sufficient to place a patient in that category 
and these are:   
1. Mild intermittent: asthma is intermittent when FEV1 (% predicted)  80%, daytime 
symptoms < 1 per week, and nocturnal symptoms  2 per month. 
2. Mild persistent: asthma is mild persistent when FEV1 (% predicted )  80%, daytime 
symptoms > 1 per week with < 1 per day, and/or nocturnal symptoms > 2 per month 
but < 1 per week, and /or attacks may affect activity. 
3. Moderate persistent: asthma is moderate persistent when FEV1 (% predicted)  60% to 
< 80%, or daytime symptoms daily, or nocturnal symptoms > 1 per week, and/or 
attacks affect activity. 
4. Severe persistent: asthma is severe persistent when FEV1 (% predicted) < 60%, and 
daytime symptoms continuous, and/or nocturnal symptoms frequent, and/or limited 
physical activity exist. 
3.5 Asthma worldwide  
ER usage due to asthma attacks is highly common and represents an important place where 
specialized health care delivery is needed (Lagerlov et al., 2000). ER visits for asthma in 
most countries account for the largest consumption of direct health care spent on asthma 
and are vulnerable point in the illness to both patients and families (Smaha, 2001). 
In USA, prevention of asthma exacerbations is the primary goal of asthma care (NHLBI, 
1997). However; one third of children with asthma require ER care (Mannino et al., 2002), 
hospital care costs account for nearly 50% of the direct cost spent on asthma each year 
(Weiss et al., 1992) and asthma is the leading cause of ER admissions (Weiss et al., 1992) 
where there are almost 2 million ER visits per year of acute asthma (Weiss et al., 1992), of 
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those nearly 75% discharged home approximately 10% to 20% will relapse within  2 
weeks (Camargo, 1998-a). In Canada, 25% of $ 600 million were expended on ER visits 
and hospitalization of asthma care (Krahn et al., 1996). In the Middle East, no scientific 
statistical data are available, but the hospital admission rates are in excess of 150-200 per 
100,000 per year in some of high prevalence countries (Goren and Hellmann, 1997; Ait-
Khaled et al., 2001; AL Frayh et al., 2001), for example; in Israel, one in five asthmatic 
children visits the ER per year (Israel, MOH, 1997). 
3.5.1  Classification of acute asthma severity in ER: 
The features of classification vary from a guideline to another, but the most widely 
accepted and practiced is the GINA classification (GINA, 2002). According to GINA 
guidelines 2002, the presence of several parameters but not necessarily all, indicate the 
general classification of the attack (GINA, 2002). 
1. Mild attack: the patient can lie down, talk in sentences, but may be agitated. 
Respiratory rate increased, accessory muscles usually not used, wheezing only end 
expiratory, pulse /minute < 100, PEF or FEV1 (%predicted) over 80%, PaO2 < 45 
mmHg, and SaO2 > 95%. 
2. Moderate attack: the patient can talk in phrases and usually agitated. Respiratory rate 
increased, accessory muscles usually used, wheezing is loud, pulse/minute 100-120, 
PEF or FEV1 (%predicted) 60-80%, PaO2 >60 mmHg and/or PaCO2< 45 mmHg, and 
SaO2 91-95%. 
3. Severe attack: the patient can talk in words only and usually agitated. Respiratory rate 
often > 30/minute, accessory muscles usually used, wheezing is usually loud, 
pulse/minute > 120, PEF or FEV1 (%predicted) < 60%, PaO2 < 60 mmHg and/or 
PaCO2 > 45mmHg. 
4. Respiratory arrest imminent: the patient is drowsy or confused. Respiratory rate 
paradoxical, accessory muscles with paradoxical movement, wheezing is absence, and 
bradycardia exist. 
3.5.2  Assessment of acute asthma in ER: 
Physiologic outcomes are the most standardized procedures in assessing clinical outcomes 
in asthmatics patients at the ER (Crim, 2000). However, pulmonary function testing 
(spirometry and peak flow meter) is used primarily to gauge the severity of the patients' 
asthma and monitor response to therapy (GINA, 2002). 
1. History and physical examination 
Asthma attack may be difficult to be diagnosed and misdiagnosis could happen with other 
disorders like, chronic obstructive pulmonary disease, bronchitis, and congestive heart 
failure. As a result it may be possible that the patient is suffering from another condition 
with similar symptoms. For example, if the patient has productive cough every day with 
little change from one day to the next, it is more likely to be bronchitis, while if he 
experiences breathlessness after exercise which worsen over time, chronic obstructive 
disease should be considered (Ait-Khaled and Enarson, 2005). However, chest pain and 
tightness may be more related to ischemic heart disease (Ait-Khaled and Enarson, 2005). 
Thus assessing the patient s history, variability of symptoms over time, causal and triggers 
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to current attack, hospital admissions, home and work environment, family history of 
atopy, and response to prior treatment should be added in diagnosis (GINA, 2002).  
Physical and physiologic examinations (temperature, pulse/minute, respiration, PaO2, 
PaCO2, SaO2, breath, wheeze, speaking, accessory muscle use, and mental state) are also 
important in assessing the acute attack of asthma and play a major role in classification the 
level of acute severity (GINA, 2002). 
2. Spirometry 
Spirometer is the most common tool used in both clinical practice and research studies to 
evaluate patients asthma severity. It is considered as an excellent procedure for 
documenting changes in asthma because it is easy to perform, but effort dependant, thus 
patients experience, education, and demonstration are necessary to get best result (Noviski 
et al., 1991). It is also a sensitive and more objective when compared to patients clinical 
symptoms (GINA, 2002). 
The main indices from spirometry testing are; FEV1, FVC, and ratio of FEV1/FVC. 
According to GINA (GINA, 2002), FEV1 (%predicted) > 80% indicate mild attack,  60% 
to  80% indicate moderate attack, and < 60% indicate severe attack. Those attended the 
ER with asthma, usually have an FEV1 between 30% to 80% of predicted (NHLBI, 1997; 
Emerman et al., 1999). A study in Canada found that, 2 hours after initiation of intensive 
bronchodilator therapy, patients with FEV1 (% predicted)  60% had a high likelihood of 
being discharged home (Schuh et al., 1997). 
Studies have indicated under use of spirometry to both in ER and in general practice, and 
that physicians and patients have been shown to underestimate lung function and rely on 
signs and symptoms alone. It was found that spirometry is never performed to one-quarter 
of asthmatics in PHC, while in 60% of cases, spirometry is never done or is performed less 
than once a year (Lopez-Vina et al., 2003).  
3. Peak expiratory flow meter 
This apparatus measures the peak expiratory flow rate (PEFR)  which  is useful in 
monitoring clinical outcome of asthmatic patients. It is considered a suitable way to 
measure lung capacity since it easy to use and in contrast to spirometry which allows only 
infrequent measurements in medical settings. Moreover, it can be used at home, work, and 
school, but it is very effort dependant and is not a substitute as a diagnostic tool for 
severity assessment (Jackson A, 1995). During asthma attack and according to GINA 
(GINA, 2002), PEF (%predicted) > 80% indicate mild attack, 60-80% moderate attack, and 
< 60% severe attack after initiation of bronchodilator therapy. 
3.5.3  Management of asthma attack in ER: 
Many studies have been carried out to evaluate and investigate the assessment and 
management of asthma in ERs in real practice. In one study, it was concluded that, B2-
agonist, ipratropium bromide, and steroids form the cornstone of acute asthma therapy, 
while methylxanthines have no proven role (Marik et al., 2002). Moreover, prompt 
administration of oral prednisone was found to be effective in reducing the need for 
hospitalization (Scarfone et al., 1993).  Other study reported that  32% of patients attended 
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the ER with life threatening asthma attacks and 40% with severe attacks, didn t receive 
steroids. This study indicating the underuse of steroids in severe exacerbations despite their 
beneficial effect and recommended guidelines. The study also found that anti-cholinergics 
were used in a half the patients irrespective to severity features upon arrival to ER. They 
found also that, 24% with life threatening attacks were discharged home after clinical 
improvement at 2 hours despite that half of them had reached a PEF of 50% of predicted 
(Salmeron et al., 2001). 
Another study in ERs, reported that aminophyline was given to small numbers of patients 
who were already taking oral theophyline, which resulted in over dosage and severe side 
effects. The study also found that IV (intravenous)-hydrocortisone 200 mg was used in 4% 
of cases, ipratropium bromide in 7%, oral steroids in 3%, oxygen (O2) was given in only 
3%, duration of attack was usually less than 1 day, and respiratory tract infection was the 
precipitating factor for current attack in 60% of cases. PEF was recorded in 26% of cases 
before treatment and in 15% after, but no FEV1 was recorded. The study concluded lack of 
knowledge about the use of nebuliser, the current use of IV (intravenous)-aminophyline, 
and that there is a need for education of all doctors in the management and diagnosis of 
asthma (Ebden et al., 1988).  
GINA recommended several procedures for optimal asthma treatment and management in 
the ER (GINA, 2002). These guidelines are closely consistent with many other 
international and national guidelines including the Palestinians guidelines for diagnosis and 
management of bronchial asthma (NHLBI, 1997; Australia, NACA, 2002; Abdeen et al., 
2003). 
Step 1) Initial assessment 
Include reviewing of the patient s history, vital and physical exams, and PEF or FEV1 
(%predicted). 
Step 2) Initial treatment 
Nebulised rapid acting B2-agonist one dose every 20 minute for 1-hour, oxygen (O2) to 
achieve  90% saturation in adults or  95% in children, systemic corticosteroids should be 
added if no immediate response. 
Step 3) Repeat assessment  
Repeat the patient physical exams and PEF or FEV1 (%predicted) to assess and monitor 
response to initial therapy. The patient is having moderate episode when PEF or FEV1 is 
60-80% predicted. In this case, inhaled B2-agonist and anti-cholinergic inhalation every 60 
minutes should be added, consider glucocorticosteroids, continue treatment 1-3 hours 
provided there is improvement. If the patient is having severe episode i.e. PEF or FEV1 is 
<60% predicted, inhaled B2-agonist and anti-cholinergic inhalation, oxygen, and systemic 
glucocorticosteroids should be added, consider subcutaneous, intramuscular, or 
intravenous B2-agonist, intravenous methylxanthine, and intravenous magnesium. 
Subcutaneous adrenaline may be indicated for anaphylaxis and angioedema. 
Step 4) Good response  
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If good response sustained 60 minutes, physical exams are normal, PEF or FEV1 > 70% 
predicted then discharge home. 
Step 5) Incomplete response within 1-2 hour 
When history indicate a high risk patient, physical exams indicate mild to moderate 
symptoms, PEF or FEV1 < 70%, and oxygen (O2) saturation not improving, then admit to 
hospital. 
Step 6) Poor response within 1-hour 
When history indicate a high risk patient, physical exams indicate severe symptoms,  
drowsiness, confusion exist,  PEF or FEV1 < 30% predicted, PaO2 < 60 mmHg, and 
PaCO2 > 45 mmHg then patient should be admitted to intensive care unit. 
Step 7) Follow up care  
Patients, who do not require hospitalization and discharged home, should have the 
following follow up care (GINA, 2002);  
1. Inhaled B2-agonist for symptoms relief. 
2. Consideration of oral steroids (0.5-1)mg/Kg until FEV1 is within 80% predicted. 
3. Patient education including proper medication use. 
4. A written asthma action plan if not already had. 
5. Close medical follow up including a letter to the career. 
6. Increased usual dose of inhaled steroids until symptoms are resolved. 
Patients, who require hospitalization, require the following follow up care (GINA, 2002);  
1. An outpatient s appointment.  
2. An interim written asthma plan. 
3. A letter to their general practitioner. 
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Chapter   4 
Materials and Methods 
4.1 Introduction 
This study followed the scientific methodology in its design and sample size. Further, 
ethical consideration was also followed regarding approval of this study, setting of the 
study and patients participation. Certain criteria were developed for inclusion and 
exclusion of the participants and a pilot study was carried out before the major one. 
Preparation for the field work was done including copies of the questionnaires and 
availability of other study tools. Data were collected during a two month period which 
included 121 participants. All data were entered and analyzed using the statistical software 
package SPSS 12 (SPSS Inc., 2003). Checking and cleaning phase was performed. 
However, logistic regression models were developed for both study outcomes (ER 
attendance frequency and chronic asthma severity). 
4.2 Study design and sample size 
According to the study aim and objectives, a cross sectional study and non-random 
purposive sample were used to collect information from all asthmatic patients  5 years old 
attending the emergency room of Alia governmental hospital in Hebron district through 
April 2005 to the end of May 2005.  The type of sample was chosen due to limited 
resources and records for asthma patients in our community. However, this kind of sample 
and study design could enable us to generate hypotheses which would be used for health 
services description, planning and for intervention programs but not for causal inferences. 
Similar design was used in similar settings using similar tools in various studies worldwide 
(Douglass et al., 2004, Dianne et al., 2004).  However, other follow up studies used 
prospective (Emerman et al., 1999; Salmeron et al., 2001) and retrospective designs 
(Weinmann et al., 2003), and case-control (Belessis et al., 2004) depending on medical 
records and patients charts which was not possible in the governmental hospitals in 
Palestine.  Therefore, and since it is an audit study, this design was one of the possible 
designs to be used in this study. 
Sample size calculation was used according to table (4.1).  The table shows the 
approximate 95% confidence intervals for an estimate, given prevalence of 5%, 10%, 20% 
and 50% and sample sizes of 50, 100, 200 and 300 patients. Based on these data, and given 
that some of the prevalences to be measured are in sub-groups (e.g. by severity) we would 
guess a sample size of 100 would be adequate (EL-Sharif N, September 2004, private 
communication). To ensure the accuracy of our sample size we interviewed all the 
asthmatic patients (121 asthmatic patients) aged 5 years and above who attended at the ER 
of Alia hospital during the 2 months period.  
The study population is all asthmatic patients aged 5 years and above, with final physician-
diagnosis of asthma, with or without further complications, who attended the ER of Alia 
governmental hospital in Hebron district through April 2005 to the end of May 2005.   
Patients of age less than  5 years were not included in the study to ensure the accuracy of 
diagnosis, since these patients symptoms can not be interpretated as asthma due to 
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difficulties and inaccuracy in diagnosis measures for children under 5  (Akinbami et al 
Schoendorf, 2002). 
Table 4.1: The approximate 95% confidence intervals for an estimate of sample size, given 
prevalence of 5%, 10%, 20% and 50% and sample sizes of 50, 100, 200 and 300 patients.  
95% CI, absolute and percent width of interval  
SAMPLE SIZE  

















































4.3 Study setting 
The study was carried out in the Alia governmental hospital, mainly in the ER. However, 
fifteen patients had been interviewed either at home or by telephone contact as it was 
difficult to interview them in the hospital ER. 
4.4 Administrative and ethical consideration  
1. An official letter to conduct the study in the ER of Alia hospital was sent to the 
manager of the hospital (Appendix 4.1). 
2. A permission letter to conduct the study at the ER of Alia hospital was given from the 
manager of Alia hospital (Appendix 4.1). 
3. The study was approved by the scientific research committee and the school of public 
health in AL-Quds University 
4. Explanatory letter for all participants attached to each questionnaire, which explains the 
study aim, importance, confidentiality and anonymity of the information with optional 
participation (Appendix 4.2). 
5. Of those who agreed to participate in the study, a written informed consent attached to 
each questionnaire was obtained from each or from the parents of the child following 
explaining the aim and importance of the study. 
6. No one had been given access to completed questionnaires except the researcher. The 
researcher kept himself with all processing steps of the samples and records to ensure 
the privacy and accuracy.  
4.5 Patients inclusion and exclusion criteria 
Eligible subjects to be included in this study met the following conditions: 
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1. resident in the area of study (Hebron district). 
2. attended the ER of Alia governmental hospital in the study period. 
3. had a final physician diagnosis of asthma with or without further complications. 
4. aged 5 years and above; and 
5. accept to participate in the study. 
Asthmatic patients who attend the ER for a reason other than disease were excluded.  
4.6 Study tools 
1. Questionnaire; The study questionnaire was developed by the International Union 
Against Tuberculosis and Lung Diseases (IUATLD) using the validated questionnaire 
that was used by the European Community Respiratory Health Survey Questionnaire 
(ECRHSQ) (Burney et al., 1994).  This questionnaire was adapted to the local 
Palestinian conditions (Appendix 4.3).  
Structured closed and open questions were used in the questionnaire.  The questions were 
divided to:   
1. Personal information included socio-demographic information and factors of each 
participant in terms of place of residence (city, village or refugee camp), name, age in 
years, sex, marital status, occupation, date and time of arrival and discharge from the 
hospital, address, home and cellular phone, and the highest level of education in years. 
2. Vital symptoms and severity at presentation to the ER, using markers of severity 
(temperature, pulse, respirations, PaO2, SaO2, PaCO2), pulmonary function 
measurements before and after salbutamol by measuring the FEV1 % predicted values 
best of 3 efforts, with a portable spirometer (Rudolf Riester GmbH and Co. KG, 
Germany ). Acute clinical severity assessment questions consisting of 5- items 
including breathlessness, wheezing, speaking difficulty, accessory muscle use and 
mental state, an individual was assigned to the highest score in which any feature occur 
according to GINA 2002 asthma management pocket (GINA, 2002). 
3. Treatment given in the ER and whether or not the patient was admitted to hospital or 
discharged home, and if he was finally discharged alive or dead, together with the 
medications he was discharged with. 
4. Medications being taken over the previous 3 months, their frequency, compliance with 
treatment, Co-morbidity and whether the patient was insured or not, and the insurance 
coverage of the medications (free, partially or full cost). 
5. History of individual asthma, asthma management and aspects of previous medical 
care, source of usual care and health system experiences. In terms of age when first 
diagnosed with asthma, if he ever had eczema and/or rhinitis, place of first diagnosis of 
asthma, by whom the patient was first diagnosed whether by a general or specialized 
doctor and if by a specialist, his field of specialty was identified, frequency of ER 
attendance and hospital admission in the past year, the mainly responsible for 
following the patient s asthma and his specialty and work, the time of last professional 
visits for asthma in past year, health service utilization and medication review in the 
past year, whether having access to specialist care or not, if he got a regular treatment 
for asthma or not, followed on regular basis or not. 
6. Self-management of asthma including using any remedies to help his asthma other than 
conventional ones, having a spirometer or peak flow meters at home, if the patient ask 
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the doctors questions about asthma disease and/or medications, if he understand the 
difference between the reliever and preventer medications and if he had a home 
inhalation equipment, how he found the asthma inhalers/devices are to use (easy or 
difficult), patients reported the reasons for current ER attendance and whether he got 
benefit from doctor in managing his asthma at home. 
7. Severity/Control of asthma over the three months prior to current attack. The chronic 
clinical status was categorized into four levels of severity, including; intermittent, mild 
persistent, moderate persistent and severe persistent asthma according to the criteria 
listed for severity in the GINA 2002 guidelines for  asthma management (GINA, 
2002). These criteria use daily and nocturnal symptoms, asthma exacerbations, 
physical activity limitation, and lung function to assign categories. An individual is 
assigned to the highest grade in which any feature occurs. But for the purpose of our 
study we didn t use lung function to assign chronic severity but only for acute current 
episode at the ER. 
8.  Whether the patient had repeat appearance during the study or not. For those who 
repeat appearance in our study, only severity items, markers at presentation to the ER, 
time since current attack began, medications regularly take, receive in hospital, 
discharged with were recorded and only for the first  re-appearance where we neglect 
other re-appearances, because some patients re-appeared more than one time  or even 
three  and four.  
9. Follow-up care, in terms of receiving a management plan in the ER or following 
discharge from the hospital, if he has a follow up; appointment for example after he 
leaves the ER or hospital, if he received training in inhaler use, whether the patient s 
usual career was sent a letter or not, and medication discharged with from the ER or 
hospital specially short acting B2-agonist and anti-inflammatory inhalers. 
10. Observations on height and weight for the objective measurement of FEV1 (% 
predicted).  
4.7 Pilot study  
A pre-test study was conducted as a small scale-version for the modified version of the 
questionnaire that has been used before in a study that had been carried out in Ramallah 
hospital (El_Sharif N, September 2004, private communication).  Ten patients attending 
the ER were asked to have an interview.  Their results were not included in the study 
population.  As a result of the pre-test some changes were performed including minor 
adjustments that were made to improve clarity of the questions but no major changes were 
judged necessary. The pre-test facilitate the orientation and adjustment to the sequence of 
the procedures and standardization of questions delivery to the patients by the researcher in 
the major study. This was done on 10 pre-test participants. 
4.8 Field work 
After having the approval to conduct the study in Alia hospital, the researcher had an initial 
visit to the hospital ER and other departments. In order to facilitate communication of the 
researcher with the ER and other departments' staffs, the ER-department manager 
introduced the researcher to the hospital staffs explaining his mission at the ER. The 
researcher was shown the steps and procedures that usually followed in the ER, like 
registration, admission, discharge forms, archive and filing system.  
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Patients attending the ER in the study period with asthma symptoms were invited to 
participate.  Patients were informed about the study objectives and were encouraged to 
participate by the ER staff. Interview for the entire study sample was conducted in the ER, 
except for eleven participants where the interview was conducted by telephone and four in 
their homes face to face.  
4.9 Methods of data collection 
1. ER registration file: We reviewed all the emergency registration file,  from April to the 
end of May 2005, to collect information about the number of patients attending the ER, 
gender, and age distribution in the study period.  We also tried to get the patients vital 
characteristics, medications discharged with, and follow up care from the file. 
2. We used the study questionnaire through interviewing, face to face interview. 
3. Observations on height and weight were recorded for all participants during the study 
period. The researcher took the measurements by using one constant standard scale. 
Height was measured to the nearest centimeter without shoes on using height scale 
(Gold, Power Tape Professional). Weight was measured with the patients' clothes on, 
but without footwear to the nearest 1 Kg. 
4. Pulmonary function and patients lung capacity before and after taken salbutamol was 
assessed by measuring FEV1 % predicted. The best of the three efforts with a portable 
spirometer (Rudolf Riester GmbH and Co. KG, Germany) was used. Patients were 
given the proper instructions how to use the spirometer and to breathe out continuously 
for 4-5 seconds in order to give best results, the highest measurement from 3 trials was 
taken for each patient. For some patients, it was difficult to take the measurement 
before and/or after salbutamol, either because of the severity of the patient s status at 
the time of arrival to the ER or because of poor familiarity of those patients with lung 
function instruments and tests. FEV1 (% predicted) was calculated according to the 
patients' age, height, weight and sex using Hankinson s et al equation (Radeos et al., 
2004). FEV1 > 80% (predicted) indicated mild attack, 60-80 % (predicted) moderate, 
and < 60% (predicted) indicated severe attack. 
Data collection started in the first day of April through to the end of May 2005 (2 months 
period). The researcher was always on time at the ER to record the patients status upon 
arrival at the ER and for interviewing them. Patients who were included in the study were 
interviewed in the ER immediately after discharge or at the bed after admission 
procedures. Only 15 patients were interviewed out of the ER; 4 were interviewed at home 
after discharge and 11 were conducted by telephone as it was difficult to interview them in 
the ER. 
The researcher collected all data by himself to ensure accuracy (validity), ethical, cultural 
aspects of the research and participants. The average number of patients seen each day was 
two patients. The average time for filling in a questionnaire was20 minutes. In the 15 
participants were they either interviewed at home or conducted by telephone, the nurse 
staff at the ER took on his responsibility to record the patients status upon arrival at the 
ER, and took the lung function measurements before and after salbutamol, after they had 
been  given instructions and training by the researcher on how to use and record the results 
of the spirometer. The nurse staff also took the patient address and telephone number after 
explaining to him the nature and aim of the study for the researcher to contact them later 
on. 
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4.10 Methods of data analysis  
All data were entered and analyzed using the statistical software package SPSS 12 (SPSS 
Inc., 2003). Checking and cleaning phase was performed. 
The classification of the two outcome variables, i.e. ER attendance and asthma severity 
was done as follows. ER attendance: one time ER attendees were those attending the ER 
only one time in the past year including the study attendance time, and frequent ER 
attendees were those attending the ER two or more times in the past year including the 
study attendance time. Classification of asthma severity in the previous three months was 
determined by self-reported day/night time symptoms according to GINA 2002 guidelines 
(GINA, 2002).  We classified patients into mild intermittent, mild persistent, moderate 
persistent and severe persistent. In the analysis we merged mild intermittent with mild 
persistent (mild asthma), and moderate persistent with severe persistent asthma 
(moderate/severe asthma). We did such combinations because our sample size is only 121 
patients and the number of mild intermittent and severe persistent was small (less than 10 
patients).  Also studies showed that classification of asthma severity varies by the reported 
history of daytime and/or nighttime symptoms, in particular between mild intermittent and 
mild persistent symptoms (Ford et al., 2001). Analysis has been made as follows; 
1. Univariate analysis: frequencies of the study variables have been made. The relation 
between the variables and ER attendance outcome, and asthma severity outcome has 
been checked by stratifying them according to frequent attendees and one-time 
attendees (for ER attendance outcomes), and according to moderate/severe asthma and 
mild asthma (for chronic asthma severity outcomes). The association between the two 
study outcomes (ER attendance and asthma chronic severity) has been also studied. 
The Chi-Square test has been used to check for the significance of the association and 
P< 0.05 was regarded as significant. 
2. Multivariate analysis: logistic regression models for both ER attendance and chronic 
asthma severity outcome variables have been developed. In ER attendance model, 
variables that were found to be <0.05 significant in univariate analysis have been 
entered. While in asthma severity model those found to be 0.1 significant in 
univariate analysis have been entered in the model. Crude odds ratio have been 
calculated for variables <0.05 significant in univariate analysis for both study outcomes 
whether they entered in the models or not.  
4.11 Constrains and limitations of the study 
The limitations of the study include the following:  
1. The patients included in this study do not represent all patients with asthma in the local 
community. Therefore, we can not generalize the study results on the community. 
However, they do represent a highly informative group of treatment failures (Joseph et 
al., 1999; Montealegre et al., 2002) and in a disease with wide spectrum of severity like 
asthma, this group represents the most costly group in terms of both financial and 
economic burden (Weiss et al., 1992; Weiss et al., 1993;  Sullivan et al., 1996). 
2. The study setup, governmental hospital, does not represent services at other private or 
non-governmental hospitals. 
3. This study is a recall and self-reported study, therefore the bias of recalling might have 
an affect on the outcome. However, some studies showed that self-reporting is an 
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accurate method of identifying asthma hospital ER-visits, outcomes, and the 
occurrence or absence of relevant clinical event (Ruffin et al., 1998). Others showed 
that; the attack of asthma, which is a crucial experience for a patient and his family, is 
less likely to be influenced by recall bias (NHLBI, 1997; Boulet et al., 1999). 
4. Chronic asthma severity was classified according to day/night time self-reported 
symptoms according to GINA 2002 guidelines (GINA, 2002). However, this way of 
classification has been used by similar studies (Ford et al., 2001; Burney et al., 2004, 
unpublished). 
5. This study is also limited by time of data collection (two month period) and sample 
size (121 participants). Further, this led to some wide confidence intervals when 
developing the regression models. 
6. We were not be able to record some vital characteristics ( temperature, pulse,  
respirations, PaO2, SaO2, and PaCO2 ) of the patients upon their arrival at the ER,  
because they were not measured by the ER-staff.   Thus, we could not use it when 
applying the GINA definition. 
7. Due to the situation of the patients at the ER, many refused to cooperate to do 
spirometry which lead to lose of data at these variables. 
4.12 Summary 
Our study took two month period in order to collect the data in the questionnaire form. 
According to study aim and objectives a non random purposive sample was used to collect 
information from 121 patients aged  5 years who attended the ER of Alia hospital. Nearly 
all asthma patients of similar age ( 5 years) who attended the ER met the inclusion 
criteria.  
The pilot study enabled us to better understand the setting of the study and the sequence of 
delivering the questions in the questionnaire. Further, the ethical consideration followed in 
this study enabled us to look for the required information in the patients' medical files and 
records. The patients participated in this study understood the study and their was an 
encouragement from them as well as the hospital administration and ER staff.   
Most of the patients in this study had poor familiarity with the spirometer and we faced 
problems in performing the tests although close information were given on how to use it 
properly. Data were analyzed using the statistical software package SPSS 12 (SPSS Inc., 
2003) in away to met the study objectives using Chi-squire, crude odds ratio and logistic 
regression models. However, some wide confidence intervals were observed regarding 





The results of this study were divided into two parts: univariate results, and multivariate 
results.  
We divided the univariate results analysis into three parts; (1) a description of study 
population (asthma patients); (2) services provided for patients at the health care system; 
(3) protocols of asthma treatment in the previous three months and after ER discharge.  In 
each part we stratified study variables by frequency of attending the emergency rooms (ER 
attendance times: one time ER attendees and frequent ER attendees in the past year), and 
by asthma severity in the previous three months (mild asthma and moderate/severe 
asthma).   
In the multivariate analysis we developed two logistic regression models for ER attendance 
and chronic asthma severity outcomes.  
5.2 Univariate analysis 
5.2.1  Study population characteristics: 
The study population is all asthmatic patients  5 years of age attending the ER of Alia 
governmental hospital in Hebron district from April 2005 to the end of May 2005. In total 
we investigated 121 asthmatic patients during the study period, of which 73.5% (n=89) 
used to attend ER frequently (two or more times in the past year).   Asthma severity was as 
follows:  54.5% of the patients had mild asthma (n=66: 9 mild intermittent and 57 mild 
persistent), while 45.5% of the patients had moderate/severe asthma (n=55: 42 moderate 
persistent and 13 severe persistent). 
As shown in Table (5.1) 11,448 patients of all age groups attended the ER in the study 
period, but only 1786 patients (15.6%) had respiratory disorders. Patients  5 years of age 
were only included in the study (n=912) of whom 121 patients (13.3%) had asthma 
symptoms as diagnosed by the physicians in the ER (Table 5.1).   
Table 5.1: Total number of patients seen in Alia ER by sex and respiratory disorders during 
the period of the study by age groups in Alia governmental hospital. 
Those with respiratory disorders Age (years) Male   Female  Total  
 Male  Female  Total  
 (0-  4) 1974 1224 3198 514 360 874 
(5-19)    2390 1152 3542 206 138 344 
(20-49) 1598 1296 2894 162 180 342 
(50-64) 504 470 974 26 78 104 
(>64) 510 330 840 52 70 122 
Total  6976 4472 11448 960 826 1786 
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Out the 121 patients with asthma symptoms 53% were males and 47% were females (Fig. 
5.1) and 63% were city residents (Fig. 5.2). Three quarter (77%) were married (Fig. 5.3).  
The patients mean age was 47 years (5 to 83 years, standard deviation 18.5 years, and 
median 48 years), of which 44% in the age group 20-49 years (Fig. 5.4). The majority 
(50.4%) had 0-6 years of education but only 9% had > 12 years of education (Fig. 5.5). 























































Figure 5.6: Distribution of study population by occupation. 
Table (5.2) shows the characteristics of ER attendees and asthma severity.  Of the 121 
patients, 73.6% (n=89) were frequent ER attendees compared to 26.4% (n= 32) one-time 
ER attendees (the mean for frequent ER attendees was 6.7 visits, standard deviation=7, 
median= 4).  No statistical difference was found by age of the patients, gender, level of 
education, marital status and occupation, but place of residence showed that patients living 
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in cities were shown to visit ER more frequently compared to villages and rarely by those 
living in refugee camps (p< 0.05) (Table 5.2).  
Mild asthma was seen in 54.5% of patients (n=66) and 45.5% of patients (n=55) had 
moderate/severe asthma.  No difference was found between the 2 genders or between the 
cities, villages or refugee camps residence.  However, single patients were more likely to 
have mild asthma, but no difference was seen for married (p< 0.05). This association 
between marital status and asthma severity might be due to age as a confounder. Younger 
patients were more likely to have mild asthma compared to older patients (p< 0.05).  
Table 5.2: Distribution of ER attendees in the past year and asthma severity by socio-
demographic characteristics in Alia governmental hospital. 


















n(%) n(%) n(%) n(%) n(%) 
Sex        
Male 64 (52.9) 19 (59.4) 45 (50.6) 0.392 39 (59.1) 25 (45.5) 0.135 
Female  57 (47.1) 13 (40.6) 44 (49.4)  27 (40.9) 30 (54.5)  
Place of residence         
City 76 (62.8) 17 (53.1) 59 (66.3) 0.038 45 (68.2) 31 (56.4) 0.123 
Village 43 (35.5) 13 (40.6) 30 (33.7)  19 (28.8) 24 (43.6)  
Refugee camp 2 (1.7) 2 (6.3) 0  2 (3) 0  
Marital status        
Single  20 (16.5) 6 (18.8) 14 (15.7) 0.679 16 (24.2) 4 (7.3) 0.032 
Married  93 (76.9) 23 (71.9) 70 (78.7)  45 (68.2) 48 (87.3)  
Widow 8 (6.6) 3 (9.4) 5 (5.6)  5 (7.6) 3 (5.4)  
Age ( years )        
5-19 11 (9.1) 3 (9.3) 8 (9) 0.160 10 (15.2) 1 (1.8) 0.000 
20-49 53 (43.8) 19 (59.3) 34 (38.2)  36 (54.5) 17 (30.9)  
50-64 29 (24) 4 (12.5) 25 (28.1)  11 (16.7) 18 (32.7)  
>64 28 (23.1) 6 (18.7) 22 (24.7)  9 (13.6) 19 (34.5)  
Level of education(years)        
0-6  61 (50.4) 12 (37.5) 49 (55) 0.270 27 (40.9) 34 (61.8) 0.035 
7-9 33 (27.3) 10 (31.2) 23 (25.8)  18 (27.3) 15 (27.3)  
10-12 16 (13.2) 5 (15.6) 11 (12.4)  12 (18.2) 4 (7.3)  
>12 11 (9.1) 5 (15.6) 6 (6.8)  9 (13.6) 2 (3.6)  
Occupation        
House wife 49 (40.5) 11 (34.4) 38 (42.7) 0.156 23 (34.8) 26 (47.3) 0.032 
General worker 32 (26.4) 10 (31.2) 22 (24.7)  19 (28.8) 13 (23.6)  
Student-school  8 (6.6) 1 (3.1) 7 (7.9)  7 (10.6) 1 (1.8)  
Monthly based 
employee  
11 (9.1) 6 (18.8) 5 (5.6)  9 (13.6) 2 (3.6)  
Unemployed  21 (17.4) 4 (12.5) 17 (19.1)  8 (12.1) 13 (23.6)                                                                                                                                                                                             
* Classification according to day/night time symptoms in GINA 2002 guidelines.  
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5.2.2  The association between ER attendees and asthma severity: 
When checking the association between ER attendees and asthma severity, we found that 
54.5% of the study patients had mild asthma (Table 5.3), of which 59% were frequent ER 
attendees.  The more sever asthmatic patients were visiting ER much more frequently 
(91%), the crude odds ratio (COR) for moderate/severe asthma compared to mild asthma 
and 95% confidence interval (CI) are; (COR, 6.92; 95% CI, 2.44 to 19.62; p<0.05).  In 
further analysis, we found that the mean number of ER visits in the past year among 
patients with mild asthma was 2.1 visits and for moderate/severe asthmatic patients was 
6.7 visits. While the mean number of visits among mild intermittent asthmatic patients was 
1.8 visits, mild persistent was 2.1 visits, moderate persistent was 6.3 visits, and for severe 
persistent was 8.2 visits.  






One time ER 
attendees 
N=32 





n (%) n (%) n (%) 
Mild asthma  66 (54.5) 27 (41) 39 (59) 
Moderate/Severe 
asthma  
55 (45.5) 5 (9) 50 (91) 
0.000 
* Classification according to day/night time symptoms in GINA 2002 guidelines. 
5.2.3 Repeat appearance:  
Of the 121 patients, 29 patients re-appeared more than one time at the ER in the two months 
study period.  Out of them 25.8% where a frequent attendee at the ER in the past year and 
18.8% were not used to attend ER frequently. The appearance in the ER was not associated 
by the type of asthma they had, i.e. 25.5% of the patients had moderate/severe and 22.8% 
had mild asthma.  
5.2.4 Services provided for patients at the health care system:  
In this part of the results, data related to health insurance services utilization, source of 
care, compliance with treatment, and career services and follow up will be presented.  
5.2.4.1 Health insurance and services utilization: 
As shown in Table (5.4), 96.7% (n=117) of the patients had health insurance, which was 
significantly higher among frequent attendees compared to one-time attendees (98.9% and 
90.6%, respectively, p <0.05), but was not significantly different for asthma severity. 
Health insurance was reported to cover asthma drugs by 14%, with no significant different 
by ER attendance frequency nor for asthma severity. Patients with moderate and severe 
asthma reported going for the same facility always for follow up and getting more 
regularly their treatment compared to mild asthma (p< 0.05)  ( Table 5.4).       
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Table 5.4: Distribution of ER attendees groups in the past year and asthma severity by 
health care services utilization in Alia governmental hospital (percentages are yes 
answers).  

















n (%) n (%) n (%) n (%) n (%) 
Health insurance  117 (96.7) 29 (90.6) 88 (98.9) 0.025 63 (95.5) 54 (98.2) 0.403 
Insurance covers 
asthma drugs  
17  (14) 4 (12.5) 13 (14.6) 0.769 12 (18.2) 5 (9.1) 0.152 
Access to 
specialist care 
77 (63.6) 20 (62.5) 57 (64) 0.876 40 (60.6) 37 (67.3) 0.448 
Go to same 
facility always 
56 (46.3) 14 (43.8) 42 (47.2) 0.738 25 (37.9) 31 (56.4) 0.042 
Regular treatment  52 (43) 10 (31.3) 42 (47.2) 0.118 16 (24.2) 36 (65.5) 0.000 
Medication 
review in past 
year  
17 (14) 2 (6.2) 15 (16.9) 0.139 7 (10.6) 10 (18.2) 0.232 
* Classification according to day/night time symptoms in GINA 2002 guidelines. 
5.2.4.2 Services, diagnosis and paying for medications:  
This study shows that 52.9% of the patients were first diagnosed with asthma between the 
age 20-49 years, of which 51.7% were frequent ER attendees.  The difference between the 
two study groups was not significant (p >0.05). In this study, it was more likely that there 
is no difference between frequent and one-time ER attendees regarding age when first 
diagnosed of asthma. The majority of patients (52.9%) of study population have been first 
diagnosed at the clinic. There was no significant difference by first diagnosis by a 
specialist or by a general physician on the attendance of ER.  Patients (45%) reported using 
always same facilitate when having asthma attacks, with no difference between one-time 
ER attendee compared to frequent ER attendee.   Only 14% of the patients reported having 
their medications for free and 74% reported that it was covered partially.  Paying fully for 
medications was shown to be higher among one-time attendees compared to others 
(p<0.05) (Table 5.5). 
5.2.4.3 Compliance with treatment: 
Concerning compliance with asthma treatment, 43% of the total study population reported 
their inability to afford or obtain medications, with no significant difference by frequency 
of ER attendees (p>0.05).  However, for asthma severity there was a significant statistical 
difference between mild asthma compared to moderate/severe asthma by affording, 
obtaining, and needing them (P< 0.05) (Table 5.5).  
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Table 5.5: Distribution of ER attendees in the past year and asthma severity by health care 
utilization and treatment coverage in Alia governmental hospital.   
ER attendees Asthma severity* 
Total 
N= 121 
One time  
N=32  
Frequent   
N=89 







n (%) n (%) N (%) n (%) n (%) 
Age when first diagnosed of asthma 
    0-4 yrs  5 (4.1) 3 (9.4) 2 (2.2) 0.289 4 (6) 1 (1.8) 0.201 
  5-19 yrs 19 (15.7) 4 (12.5) 15 (16.9)  13 (19.7) 6 (10.9)  
20-49 yrs 64 (52.9) 18 (56.3) 46 (51.7)  36 (54.5) 28 (50.9)  
50-64 yrs 22 (18.2) 6 (18.8) 16 (17.9)  9 (13.6) 13 (23.6)  
  > 64 yrs 11 (9.1) 1 (3.1) 10 (11.2)  4 (6) 7 (12.7)  
Center where first diagnosed of asthma at 
Clinic  64 (52.9) 20 (62.5) 44 (49.4) 0.229 36 (54.5) 28 (50.9) 0.128 
Hospital clinic  18 (14.9) 2 (6.3) 16 (17.9)     6 (9.1) 12 (21.8)  
Hospital ER 39 (32.2) 10 (31.3) 29 (32.6)  24 (36.4) 15 (27.3)  
Professional by whom first diagnosed 
General doctor  52 (43) 18 (56.3) 34 (38.2) 0.077 31 (47) 21 (38.2) 0.331 
Specialized doctor  69 (57) 14 (43.8) 55 (61.8)  35 (53) 34 (61.8)  
Go  to same facility always (yes) 
Private clinic  20 (16.5) 5 (15.6) 15 (16.9) 0.984 9 (13.6) 11 (20) 0.058 
Public clinic  8 (6.6) 2 (6.3) 6 (6.7)  6 (9.1) 2 (3.6)  
Out-patient clinic  6 (5) 2 (6.3) 4 (4.5)  1 (1.5) 5 (9.1)  
Primary health care  22 (18.2) 5 (15.6) 17 (19.1)  9 (13.6) 13 (23.6)  
Use same facilitate when has attacks 
Always  55 (45.5) 15 (46.9) 40 (44.9) 0.009 31 (47) 24 (43.6) 0.344 
Often   27 (22.3) 2 (6.3) 25 (28)  13 (19.7) 14 (25.5)  
Sometimes   16 (13.2) 3 (9.4) 13 (14.6)  6 (9.1) 10 (18.2)  
Rarely  13 (10.7) 7 (21.9) 6 (6.7)  9 (13.6) 4 (7.3)  
Never  10 (8.3) 5 (15.6) 5 (5.6)  7 (10.6) 3 (5.5)  
Pay for medicines 
Free  17 (14.0) 4 (12.5) 13 (14.6) 0.041 12 (18.2)   5 (9.1) 0.071 
Partially covered  89 (73.6) 20 (62.5) 69 (77.5)  43 (65.1) 46 (83.6)  
Full cost  15 (12.4)   8 (25.0)   7 (7.9)  11 (16.7) 4 (7.3)  
Reasons for not taking all medications 
Don t need  37 (30.6) 13 (40.6) 24 (27.0) 0.124 27 (40.9) 10 (18.2) 0.001 
Can t afford  31 (25.6)   5 (15.5) 26 (29.2)  12 (18.2) 19 (34.5)  
Can t obtain  21 (17.4)   3 (9.4) 18 (20.2)    6 (9.1) 15 (27.3)  
Don t want  32 (26.4) 11 (34.4) 21 (23.6)  21 (31.8) 11 (20.1)  
* Classification according to day/night time symptoms in GINA 2002 guidelines. 
5.2.4.4 Specialty visiting and admission to a hospital: 
Table (5.6) describes the characteristics and frequency use of asthma care provider by 
study population. The results show 11% of our sample did not see a professional  for 
asthma in the past year. The frequent attendees of the ER were those who reported seeing a 
professional more than twice a year compared to one-time attendees (p<0.05). Similar 
results were seen by severity of the disease, i.e. patients with more sever asthma where 
used to see a professional  more times a year compared to mild asthmatic patients (p<0.05).   
Concerning the last time seeing this professional, 63% of our sample visited a professional 
in less than a month from attending ER, of whom 53.2% had moderate/severe asthma.  
Only 21% of 54 specialists followed asthma patients were specialized in chest diseases or 
asthma (Table 5.6). 
Most patients (87 out of 121 patients) were admitted to the hospital, and 40% of the study 
population was admitted in the past year.    The admission was among the frequent 
attendees of the ER, and was among the sever asthmatic patients (p<0.05).  The number of 
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admissions to the hospital was also higher among frequent ER attendees and among sever 
asthmatics (p<0.05) (Table 5.6). 
Table 5.6: Distribution of ER attendees groups in the past year by attending ER, seeing or 
follow up by a specialist and type of specialty.  
ER attendees Asthma Severity * 
Total 
N=121 
One time  
N=32  











n(%) n(%) n(%) n(%) n(%) 
Times attended ER in the past year  
One time 32 (26.4) 32 (100) 0 0.000 27 (40.9) 5 (9.1) 0.000 
2-3 times 39 (32.2) 0 39 (43.8) 19 (28.8) 20 (36.4)  
4-5 times 19 (15.7) 0 19 (21.3) 10 (15.2) 9 (16.4)  
>5 times 31 (25.6) 0 31 (34.8) 10 (15.2) 21 (38.2)  
Times visited a professional in past year 
zero 14 (11.6) 8 (25) 6 (6.7) 0.001 13 (19.7) 1 (1.8) 0.001 
1-2  30 (24.8) 13 (40.6) 17 (19.1)  21 (31.8) 9 (16.4)  
3-4 29 (24) 4 (12.5) 25 (28.1)  13 (19.7) 16 (29)  
5-6 11 (9.1) 3 (9.4) 8 (9)  7 (10.6) 4 (7.3)  
> 6 37 (30.6) 4 (12.5) 33 (37.1)  12 (18.2) 25(45.5)  
Last time seen by a professional 
< 1 wk  26 (21.5) 10 (31.3) 16 (18) 0.035 13 (19.7) 13 (23.6) 0.042 
1 wk- 1 mnt 51 (42.1) 9 (28.1) 42 (47.2)  23 (34.8) 28 (50.9)  
>1mnt-6 mnt  20 (16.5) 3 (9.4) 17 (19.1)  11 (16.7) 9 (16.4)  
>6 mnt- 1 yr  11 (9.1) 3 (9.4)   8 (9)  7 (10.6) 4 (7.3)  
> 1 yr  13 (10.7) 7 (21.9) 6 (6.7)  12 (18.2) 1 (1.8)  
Specialist field of specialty 
Internal and 
cardiology  
24 (19.8) 7 (21.9) 17 (19.1) 0.177 11 (16.7) 13 (23.6) 0.242 
Allergy/asthma 
and chest 
26 (21.5) 3 (9.4) 23 (25.8)  11 (16.7) 15 (27.3)  
Neurologist 3 (2.5) 1 (3.1) 2 (2.2)  1 (1.5) 2 (3.6)  
ENT 1 (0.8) 1 (3.1) 0  1 (1.5) 0  
Admitted to hospital with asthma  
Yes<1 yr  48 (39.7) 0 48 (53.9) 0.000 17 (25.8) 31 (56.4) 0.001 
Yes, >1 yr 39 (32.2) 11 (34.4) 28 (31.5)  23 (34.8) 16 (29.1)  
Times admitted to hospital in the past year  
zero 73 (60.3) 32 (100) 41 (46) 0.000 49 (74.2) 24 (43.6) 0.008 
1-2 29 (24) 0 29 (32.6)  11 (16.7) 18 (32.7)  
3-4 13 (10.7) 0 13 (14.6)  4 (6) 9 (16.4)  
> 4 6 (5) 0 6 (6.8) 2 (3) 4 (7.3)  
* Classification according to day/night time symptoms in GINA 2002 guidelines. 
5.2.4.5 Follow up criteria: 
Follow up was done for 43% (n=52) of these patients by a specialist and 23% by the ER 
doctor, even 79% reported seeing a professional within the past 6 months of the study.   
Most patients (83%) were not followed up regularly, who mainly visited ER very frequent, 
i.e. 18 out of 21 patients followed on regular basis and who were mostly severe patients 
(14 out of 21 patients) (p<0.05) (Table 5.7).  
Half of the patients attending ER reported having follow up, with no difference by 
frequency of visiting ER or asthma severity.  But those patients were rarely having a 
management plan (9%) and quarter had a letter to their carer.  The management plans and 




In table (5.8), patients reported visiting ER majorly happened due to shortness of breathe 
(95%).   However, we did not see any significant difference by frequency of ER attendance 
nor by asthma condition.  
Table 5.7: Distribution of ER attendees groups in the past year and asthma severity by 
Follow up criteria. 
ER attendees Asthma severity * 
Total 
N= 121 
One time  
N=32 











n(%) n(%) n(%) n(%) n(%) 
Following up patient s asthma 
Specialist  52 (43) 11 (34.4) 41 (46) 0.479 23 (34.8) 29 (52.7) 0.200 
ER doctor  28 (23.1) 7 (21.9) 21 (23.6)  19 (28.8) 9 (16.4)  
GP 29 (24) 9 (28.1) 20 (22.5)  17 (25.8) 12 (21.8)  
Nurse  1 (0.8) 0 1 (1.1)  0 1 (1.8)  
Others  11 (9.1) 5 (15.6) 6 (6.7)  7 (10.6) 4 (7.3)  
Followed on 
regular basis 
21(17.4) 3 (9.4) 18 (20.2) 0.165 7 (10.6) 14 (25.5) 0.032 
Follow up after 
ER 
63(52.1) 16 (50) 47 (52.8) 0.785 33 (50) 30 (54.5) 0.618 
Management  
plan 
11 (9.1) 1 (3.1) 10 (11.2) 0.171 4 (6) 7 (12.7) 0.204 
Carer sent a 
letter  
31(25.6) 3 (9.4) 28 (31.5) 0.014 12 (18.2) 19 (34.5) 0.04 
*Classification according to day/night time symptoms in GINA 2002 guidelines. 
Table 5.8: Distribution of ER attendees in the past year and asthma severity by reported 
reasons for current ER attendance (percentages are for yes answer). 
ER attendees Asthma severity* 
Total 
N= 121 
One time  
N=32 











n(%) n(%) n(%) n(%) n(%) 
Respiratory infection 25 (20.7) 6 (18.8) 19 (21.3) 0.756 16 (24.2) 9 (16.4) 0.286 
Shortness of breath 115 (95) 29 (90.6) 86 (96.6) 0.180 61 (92.4) 54 (98.2) 0.146 
Less medication cost 17 (14) 5 (15.6) 12 (13.5) 0.765 12 (18.2) 5 (9.1) 0.152 
Misuse of asthma 
medication 
11 (9.1) 3 (9.4) 8 (9) 0.948 7 (10.6) 4 (7.3) 0.525 
Worried about asthma 
symptoms 
34 (28.1) 13 (40.6) 21 (23.6) 0.066 20 (30.3) 14 (25.5) 0.555 
* Classification according to day/night time symptoms in GINA 2002 guidelines. 
5.2.4.6 Educating asthmatic patients about asthma and its medications: 
As shown in Table (5.9), 34.7% of the patients (n=42) reported having training  
on using inhalers, with no significant difference by frequency of ER attendance or by 
asthma severity (p>0.05).  Also, written/oral information about asthma was given to less 
than 20% of the patients. Only 44.6% of the sample reported beneficial results from the 
doctor in managing their asthma at home,  this was significantly different among one- time 
and frequent attendees for ER, and among mild and moderate/severe asthmatics (p<0.05) 
(Table 5.9). Most patients preferred to have more information to understand their disease 
and the use of its medication.  This by itself could be related to the low compliance of 
taking medications among the study population (21%), of whom more sever asthmatic 
patients were more complied compared to mild  asthmatic patients (p<0.05).   Home 
inhalers equipment or devices were used by only 25% of the study population and nearly 
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44% found them not easy to be used. And this was significantly different among ER 
attendees groups (p<0.05). These devices were used more among sever asthmatic patients 
compared to patients with mild asthma (35% and 18%, respectively; p<0.05) (Table 5.9). 
Using remedies was very popular among the study population (76%), and was used by 
90% of the sever asthma patients compared to 63% of mild asthmatics (p<0.05) (Table 
5.9).   
Table 5.9: Distribution of ER attendees groups in the past year and asthma severity by 
patient s education about asthma and its medications. 
ER attendees Asthma severity * 
Total 
N= 121 
One time  
N=32 
Frequent   
N=89 







n(%) n(%) n(%) n(%) n(%) 
Training in inhalers use  42 (34.7) 9 (28.1) 33 (37) 0.362 25 (37.9) 17 (30.9) 0.423 
Given oral/written 
information  




28 (23.1) 7 (21.9) 21 (23.6) 0.843 17 (25.8) 11 (20) 0.455 
Ask doctor about asthma 
drugs 
48 (39.7) 14 (43.8) 34 (38.2) 0.582 24 (36.4) 24 (43.6) 0.415 
Benefit from doctor in 
asthma management at 
home 
54 (44.6) 21 (65.6) 33 (37) 0.005 39 (59.1) 15 (27.3) 0.000 
Like more information on 
asthma disease  
100(82.6) 27 (84.4) 73 (82) 0.763 57 (86.4) 43 (78.2) 0.237 
Like more information on 
asthma drugs  
93 (76.9) 26 (81.3) 67 (75.3) 0.492 53 (80.3) 40 (72.7) 0.325 
Home inhalation 
equipment  
31 (25.6) 7 (21.9) 24 (27) 0.572 12 (18.2) 19 (34.5) 0.04 
Take all your medicines  26 (21.5) 5 (15.6) 21 (23.6) 0.346 8 (12.1) 18 (32.7) 0.006 
Other remedies use (non 
conventional)  
92 (76) 22 (68.8) 70 (78.7) 0.260 42 (63.6) 50 (90.9) 0.000 
Find inhalers/devices to use 
1. Easy  68 (56.2) 23 (71.9) 45 (50.6) 0.037 41 (62.1) 27 (49.9) 0.150 
2. Difficult  53 (43.8) 9 (28.1) 44 (49.4)  25 (37.9) 28 (50.9)  
* Classification according to day/night time symptoms in GINA 2002 guidelines. 
5.2.5 Asthma treatment protocol: 
5.2.5.1 Medications regularly taken in past three months:  
As shown in Fig. (5.7), 66.9% of the patients reported using oral antibiotics occasionally, 
with no difference by frequency of ER attendance, cough mixtures by 39%, but anti-
histamine was used by 15% of the patients.  Theophyline was used by 66% of the patients, 
which was more frequent among the frequent ER attendees (p>0.05).  Inhaled Short B-
agonist with more prescribed compared to oral, and the frequent ER attendees take the 
inhaled short B-agonist most days compared to one time attendees (p<0.05).  Inhaled 
steroids were taken by 50% of the patients and was taken more by the frequent ER 
attendees compared to one-time attendees (p=0.05).  Nebulized short B-agonist with taken 
occasionally by 24% of the patients.  
In Fig. (5.8), 80% of moderate/severe patients used oral theophyline compared to 54% of 
mild asthmatics (p<0.05). For inhaled B-short agonist, 50% of moderate/severe used most 
days compared to 17% of mild asthmatics (p<0.05).  Similarly, inhaled steroids was used 
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by 60% of the moderate/severe asthmatics (40% most days) compared to mild asthmatics 
(9% most days) (p<0.05).  Nebulized short acting B-agonist was used occasionally by 32% 






























































































































































































































One time ER attendees  
Frequent  ER attendeesOral Inhaled Parenteral /
Nebulized 
Values are given as total (%) and percentages of each group, the non-presented data=none. 




















































































































































































































Values are given as total (%) and percentages of each group.The non-presented data=none. 





5.2.5.2 Oral steroid and currently use of essential inhaled medications in the past 
year: 
Fig. (5.9) shows that 47% of the patients used oral steroids in the past year (26% used 1-4 
courses /year) and inhaled Beclomethasone (42% used the 500mcg/day), and inhaled short 
B-agonist by 80% (51% used 1 cannister/month). No significant difference was seen 
between frequent ER attendees and one-time attendees in the use oral steroids courses 
(p>0.05).  But frequent ER attendees used inhaled Beclomethasone much more frequently 
compared to one time attendees (p=0.05), similarly used inhaled short B-agonist (p<0.05). 
In Fig. (5.10), moderate/severe asthmatics (30%) used oral steroids more frequently than 
mild asthmatics (12%) ( 5 courses/year), but 31% of mild asthmatics used 1-4 courses a 
year compared to 20% of moderate/severe asthmatics (p<0.05).  The moderate/severe 
patients used inhaled Beclomethasone and inhaled short B-agonist more frequently and in 
higher concentrations (78% used 1 cannister/month) compared by mild asthmatics (29% 

















































































One time ER attendees
Frequent  ER attendees  
Values are given as total (%) and percentages of each group.The non-presented data=none. 





















































































Moderate/Severe  asthma 
Values are given as total (%) and percentages of each group.The non-presented data=none. 





5.2.5.3 Treatment failure by inhaled beclomethasone: 
Based on GINA guidelines 2002 (GINA, 2002), the International Union Against 
Tuberculosis and Lung Disease 2005 (Ait-Khaled and Enarson, 2005) recommended 4 step 
approach for asthma treatment by beclomethasone. According to this recommendation,  
mild persistent asthma patients should be at least on 500mcg/day inhaled beclomethasone, 
moderate persistent at least on 1000mcg/day, and severe persistent at least on 
2000mcg/day. 
Table (5.10) shows the distribution of inhaled beclomethasone doses by persistent asthma 
severity in our study.  Only 21 (36.8%) out of 57 (100%) of mild persistent were 
adequately treated, 4 out of 42  patients (9.5%) of moderate persistent were adequately 
treated, and  none of the severe persistent had been adequately treated in regard to inhaled 
beclomethasone. Of the total patients with persistent asthma (112) only 22.3 %( n=25) 
were adequately treated and the other 77.7 %( 87) were under-treated by inhaled 
beclomethasone. 
As Table (5.11) shows, of those who were adequately treated, 22.3% (7.3% 
moderate/severe persistent and 36.8% mild persistent), with a significant difference 
between the two groups regarding treatment adequacy (p <0.05). The crude odds ratio 
(COR) and 95% confidence interval (CI) for under-treated compared to adequately-treated 
in moderate/severe persistent asthma are; COR, 7.4; 95% CI, 2.3 to 23.5. This means that 
moderate/severe persistent asthmatics are more likely to be under-treated than mild 
persistent asthma in regard to inhaled anti-inflammatory beclomethasone. 
Table 5.10: Distribution of persistent asthma severity* in past 3 months by 
Beclomethasone inhaled currently use doses. 











n(%) n(%) n(%) 
500mcg/day 20 (35) 22 (52.4) 5 (38.5) 
1000mcg/day 1 (1.8) 3 (7.1) 2 (15.4) 
2000mcg/day 0 1 (2.4) 0 
None  36 (63.2) 16 (38) 6 (46.2) 
* Classification according to day/night time symptoms in GINA 2002 guidelines. 
Table 5.11: Distribution of treatment adequacy by persistent asthma severity* in past 3 
months. 
Treatment adequacy  Total 
n= 112 







n (%) n (%) n (%) 
Adequately-treated  25 (22.3) 21 (36.8) 4 (7.3) 
Under-treated  87 (77.7) 36 (63.2) 51 (92.7) 
0.000 
*Classification according to day/night time symptoms in GINA 2002 guidelines. 
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5.2.5.4 Medications discharged with: 
In general prescription of medications did not exceed for 15%of the  
patients, since most patients came with their medications.  But, 50% of the  
patients were prescribed antibiotics and 25% cough mixtures when discharged  
from the ER. Results did not show any significant difference in  
prescribing medications between one-time attendees and the frequent ER  
attendees (Fig. 5.11).  This was also seen when comparing mild asthmatic and  

































































































































































































One time ER attendees  




Values are given as total (%) and percentages of each group. The non-presented data=none. 











































































































































































































Values are given as total (%) and percentages of each group The non-presented data=None. 





5.3  Multivariate logistic regression analysis 
To investigate which variables could determine the ER attendance and asthma severity, 
two multivariate models were developed, i.e. a model for ER frequency attendance in the 
past year as the outcome variable, and the other for asthma severity in the past three 
months as an outcome.  
5.3.1  ER attendance model: 
Variables with a significant level less than 0.05 in the univariate analysis were included in 
the model. However, some of the these variables could not be added due to the fact that the 
number of patients in some of the categories were less than 10, so the Pearson could be 
calculated accurately.  Therefore, we merged some of the categories into two categories, 
and those continued having a p value <0.05 in the univariate analysis we still added them 
to the model. When re-categorize place of residence into city/refugee, and village it was no 
more <0.05 significant but we still add it in the model, so to adjust for it. City is considered 
as an urban area and refugee camps as a semi-urban so we added them in one category as 
villages are considered as rural areas. 
Table (5.12) shows the multivariate logistic regression model for ER attendance times. As 
shown in the Table (5.12), any past admission to hospital due to asthma remains a 
significant risk factor for the attendance to ER (OR, 17; 95% CI, 2.15 to 147). Moreover, 
patients  reporting getting a benefit from their doctor in managing their asthma at home 
were significantly inversely associated with frequent ER attendances compared to those 
reporting no benefit (OR, 0.07; 95% CI, 0.008 to 0.64). Meanwhile, reporting difficulty in 
using asthma inhalers/devices remains significantly a risk factor for frequent ER 
attendances compared to those reporting an easy use. An often use of the same facilitate 
when has asthma attacks also found to be significantly more associated with frequent 
attendees to ER compared to never use (Table 5.12). 
Moderate/severe asthma was more associated with frequent attendance compared with 
mild asthma but this was not significant (OR, 3.33; 95% CI, 0.35 to 31.17, p>0.05).   
Frequent attendees were  4.1 times more to be given a letter to their carer upon ER 
discharge compared to  not given a letter (95% CI, 0.3 to 55.12;p>0.05). Paying partially or 
full cost were also inversely related to frequent attendees compared to paying free of 
charge, but the relations were not significant. 
Any time visit to a professional in the past year was also positively associated with 
frequent attendees compared to zero visit, but again the association failed to be significant. 
An occasional and/or most days regular use of inhaled short B-agonist were positively 
associated with frequent attendances to ER compared to none regular use, but with no 
statistical significance relations.  The contrary was observed regarding an occasional 
and/or most days regular use  of inhaled steroid, where an inverse association was 
observed with frequent ER attendances compared to none regular use, but here also no 
significance in the association is observed (Table 5.12). 
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Table 5.12: Multivariate logistic regression  analysis model for factors associated with 
frequent ER attendees. 
Socio-demographic COR AOR 95% CI P value 
Place of residency *     
City and refugee camps 0.74 6.77 0.88-51 0.06 
Village  1.00 1.00 
Asthma severity
   
Moderate/severe  6.92 3.33 0.35-31 0.29 
Mild asthma  1.00 1.00 - 
Health services utilization 
Has health insurance     
Yes 9.10 0.30 0.002-50 0.64 
No  1.00 1.00 
Pay for medicine     
Partially covered 1.06 0.11 0.005-2.45 0.16 
Full cost  0.26 0.16 0.003-9.92 0.38 
Free  1.00 1.00 
Times visited a professional in past year     
1-2 1.74 2.46 0.003- 2257 0.79 
3-4 8.33 23 0.01-42323 0.40 
5-6 3.55 2.23 0.001-5152 0.83 
>6 11.0 6.75 0.005-9290 0.60 
Zero 1.00 1.00 - - 
Last time seen by a professional     
< 1 wk 1.86 0.01 0.000-21 0.26 
1 wk-1mnt 5.44 0.66 0.000-888 0.91 
>1mnt-6 mnt 6.61 1.63 0.001-1898 0.89 
>6 mnt-1 year 3.11 4.12 0.003-6561 0.70 
> 1 year 1.00 1.00 - - 
Use  same facilitate when has attack       
Always 2.66 28 0.37-2229 0.13 
Often 12 709 6.73-74754 0.006 
Sometimes 4.33 20 0.40-1059 0.13 
Rarely 0.85 15 0.21-1162 0.21 
Never 1.00 1.00 - - 
Ever admitted to hospital with asthma**     
Yes 11.16 17 2.15-147 0.008 
No  1.00 1.00 - - 
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Table 5.12: continued  
Usual carer sent a letter     
Yes 4.43 4.10 0.30-55 0.28 
No 1.00 1.00 - - 
Benefit from doctor in asthma 
management at home     
Yes  0.30 0.07 0.008-0.64 0.01 
No  1.00 1.00 - - 
Medications 
   
Find inhalers/devices use     
Difficult  2.49 83.36 3.89-1782 0.005 
Easy  1.00 1.00 - - 
Inhaled short B-agonist regularly take     
Occasionally 1.60 516 0.02-9672165 0.21 
Most days 4.40 127 0.008-2123886 0.32 
None  1.00 1.00 - - 
Inhaled steroid regularly take     
Occasionally 1.68 0.007 0.00-3.64 0.12 
Most days 4.48 0.02 0.00-4.16 0.15 
None 1.00 1.00 - - 
Beclomethasone inhaled currently use#     
Yes  3.13 118 0.38-35933 0.10 
No 1.00 1.00 - - 
Short B-agonist inhaled currently use     
<1 cannister/month 0.80 0.004 0.00-91 0.28 
1 cannister/month 4.05 0.04 0.00-639 0.51 
None 1.00 1.00 - -  
COR: Significant crude odds ratio are bolded. AOR: Adjusted odds ratio. *Place of residency variable was 
re-categorized into city and refugee camp, and village since 2 cases were residing in  refugee camps among 
study population (see Table 5.2).**Ever admitted to hospital with asthma variable was re-categorized into 
yes and no since no case reported an admission in a period of less than a year and was attending the ER once 
in that period  (see Table 5.6). # Beclomethasone currently inhaled use was re-categorized into yes and no 
answer since very few used concentrations (n=7) >500 mcg/day (see Fig. 5.9). 
Note: (1) times admitted to hospital with asthma in past year was not included in the model since no case was 
admitted 1 time among one-time attendees (see Table 5.6). (2) Oral antihistamine discharged with variable 
not entered because only one case among frequent attendees discharged with it (see Fig. 5.11). 
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5.3.2  Asthma severity model: 
Variables with  0.1 significance in univariate analysis were entered in the model. 
However, some of the these variables could not be added due to the fact that the number of 
patients in some of the categories were less than 10, so the Pearson could not be calculated 
accurately (Table 5.13, below).  We did not merge any variable in this model into two 
categories as they failed to be  0.1 significant or they included a few number of patients 
which made them statistically unaccepted in the model. Variables that did not entered in 
the model but showed <0.05 significance in univariate analysis were calculated for crude 
odds ratio as shown in Table (5.13) below. 
Table (5.13) shows the multivariate logistic regression model for asthma severity. As 
shown in the Table (5.13) patients with moderate/severe asthma were significantly more 
likely to get regular treatment (OR, 38; 95% CI, 2.19 to 682; p<0.05). Moreover, using 
other remedies (non conventional ones), and given a letter to usual carer were both 
significantly more likely to be associated with moderate/severe asthma patients compared 
to none use and not given a letter, respectively (OR, 24; 95% CI, 1.28 to 477.89; p<0.05 
and 21; 2.02 to 237; p<0.05; respectively). However, reporting benefit from their doctor in 
managing asthma at home was significantly inversely associated with moderate/severe 
asthma compared to no benefit (OR, 0.01; 95% CI, 0.001 to 0.31; p< 0.05). 
Similarly moderate/severe asthmatics reported their inability in obtaining their asthma 
medicines compared to not needing them as the reason for not taking all their asthma 
medicines (OR, 26.82; 95% CI, 1.33 to 539; p< 0.05).   
Most days regular take of oral theophyline was significantly more likely to be related to 
moderate/severe asthma compared to none use (OR, 27; 95% CI, 1.2 to 630; p<0.05). 
However, an occasional regular intake of inhaled steroid in past three months was 
significantly inversely associated with moderate/severe asthma compared to none use (OR, 
0.007; 95% CI, 0.00 to 0.42; p<0.05).  
Married patients were nearly 16 times more related to moderate/severe compared to single 
patients (OR: 16, 95% CI, 0.84 to 1.10, p>0.05) while higher levels of education were 
inversely associated with moderate/severe asthma compared to lower level (0-6 years of 
schooling). However, age and occupation could be confounders for some of variables thus 
affected some of these associations as we did not adjust for them in the model. On the 
contrary, reporting to be followed on regular basis, having home inhalation equipment, and 
taking all asthma medicines were positively associated with moderate/severe asthma 
compared to negative answers with no significances in the associations. Furthermore, 
paying partially and/or full cost for asthma medicines were positively related to 
moderate/severe asthmatics compared to free of charge payment but failed to be significant 
(ORs, 2.86 and 12; respectively ).  
As expected, moderate/severe asthma patients reported using currently  1 cannister/month 
of inhaled short B-agonist by 4.61 times more compared to none use, but statistically 
significant association was not observed (Table 5.13). Variables that did not stay in the 
model but had significant odds ratios are in Table (5.14). 
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Table 5.13: Multivariate logistic regression analysis model for factors associated with 
moderate/severe asthma. 
Socio-demographic COR AOR 95% C.I P value  
Marital status      
Married  4.26 15.99 0.84- 1.10 0.06 
Widow 2.40 0.18 0.003 9 0.40 
Single  1.00 1.00 - - 
Highest level of education      
(7-9) years of schooling 0.66 0.44 0.05 - 3.99 0.47 
(10-12) years of schooling 0.26 0.05 0.02-1.79 0.10 
> 12 years of schooling  0.17 0.59 0.02 15 0.75 
(0-6) years of schooling) 1.00 1.00 - - 
Health services utilization  
   
Get regular treatment     
Yes  5.92 38 2.19 - 682 0.01 
No  1.00 1.00 - - 
Followed on regular basis      
Yes  2.87 1.73 0.13 - 22 0.67 
No  1.00 1.00 - - 
Benefit from doctor in asthma 
management at home      
Yes  0.26 0.01 0.001 0.31 0.007 
No  1.00 1.00 - - 
Patient's usual carer sent a letter      
Yes  2.37 21.89 2.02 - 237 0.01 
No  1.00 1.00 - - 
Pay for asthma medicines     
Partially covered  2.56 2.86 0.13 62 0.50 
Full cost   0.87 12.50 0.33 - 472 0.17 
Free  1.00 1.00 - - 
Times visited ER in the past year      
1-2 5.68 4.40 0.24 78 0.31 
3-4 4.86 1.06 0.01 74 0.97 
> 4 11.34 1.34 0.04 44 0.86 
Never 1.00 1.00 - - 
Ever admitted to hospital with asthma      
Yes, < a year ago  5.92 2.20 0.02 - 246 0.74 
Yes,  > a year ago  2.26 4.34 0.27 68 0.29 
No  1.00 1.00 - - 
Times of hospital admission in past year      
1-2 3.34 0.19 0.001 - 26 0.51 
3-4  4.59 2.04 0.04 - 103 0.72 
Zero  1.00 1.00 - -  
Medications 
Have home inhalation equipment      
Yes  2.37 1.85 0.14 - 23 0.63 
No  1.00 1.00 - - 
Take all asthma medicines     
Yes  3.52 1.71 0.21 - 13 0.61 
No 1.00 1.00 - - 
Reasons for not using all asthma 
medicines     
Can't afford them 4.27 2.05 0.12 - 34 0.61 
Can't obtain them 6.75 26 1.33 - 539 0.03 
Don't want them  1.41 12 0.78 - 206 0.07 
Don't need them 1.00 1.00 - - 
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Table 5.13: continued 
Use other remedies currently 
(nonconventional ones)     
Yes  5.71 24.80 1.28 - 477 0.03 
No 1.00 1.00 - - 
Oral  theophyline regularly take     
Occasionally  1.97 2.28 0.18 27 0.51 
Most days  4.69 27.59 1.20 - 630 0.03 
None  1.00  1.00 - - 
Inhaled  steroid regularly take     
Occasionally  1.06 0.007 0.00 0.42 0.01 
Most days  6.81 4.98 0.33 73 0.24 
None  1.00 1.00 - - 
Inhaled short B-agonist currently use      
< 1 cannister / month 0.62 1.23 0.07 21 0.88  
1 cannister / month 6.78 4.61 0.31 66 0.26 
None  1.00 1.00 - - 
Oral theophyline discharged with     
Medication  1.9 2.99 0.07 - 113 0.55 
None  1.00 1.00 - - 
COR: Significant crude odds ratio are bolded. AOR:  Adjusted odds ratio. 
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Table 5.14: Variables not in asthma severity model and their crude odds ratio (COR), 95% 
confidence interval (CI), and p values.  
Age (years) COR 95% CI P value 
5-19 1.00 - - 
20-49 4.72 0.55-39 0.15 
50-64 16 1.83-145 0.01 
>64 21 2.33-191 0.007 
Occupation    
House wives 0.69 0.24-1.97 0.49 
General workers 0.42 0.13-1.30 0.13 
Students-school 0.08 0.009-0.85 0.03 
Monthly based employee 0.13 0.02-0.80 0.02 
Unemployed 1.00 - - 
Go to same facility always    
Yes  2.11 1.02-4.39 0.04 
No 1.00 - - 
Times visited a professional in past year    
Zero 1.00 - - 
1-2 5.57 0.63-49 0.12 
3-4 16 1.84-138 0.01 
5-6 7.42 0.69-79 0.09 
>6 27 3.61-231 0.003 
Last time seen by a professional    
< 1 wk 12 1.35-106 0.02 
1 wk-1mnt 14 1.76-120 0.01 
>1mnt-6 mnt 9.81 1.06-90 0.04 
>6 mnt-1 year 6.85 0.63-74 0.11 
> 1 year 1.00 - - 
inhaled short B-agonist regularly take    
Occasionally 1.45 0.52-4.06 0.46 
Most days 6.31 2.06-19.33 0.001 
None 1.00 - - 
Oral steroid in past year (courses)    
1-4 0.71 0.29-1.73 0.46 
5-9 1.64 0.45-5.95 0.44 
10-15 5.02 1.27-19.76 0.02 
Zero 1.00 - - 
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Table 5.14: continued   
Beclomethasone inhaled currently use*    
Yes 2.46 1.18-5.12 0.01 
No 1.00 - - 
COR: Significant crude odds ratio are bolded. * Beclomethasone currently inhaled use was re-categorized 
into yes and no answer since very few   used concentrations (n=7) >500 mcg/day (see Fig. 5.9). 
5.4  Summary 
In this chapter, univariate analysis was performed to describe the study population 
characteristics, health services utilization, and medications prescribed to the patients which 
were stratified by both study outcomes (ER frequency and asthma severity). The results 
were represented in tables and figures. However, variables found to be significant in this 
part of analysis were entered in logistic regression analysis and two models were 
developed, i.e. one for ER attendance frequency and the other for asthma severity in a two 
separated tables. 
The main results showed that asthma severity, and reporting difficulty in asthma 
inhalers/devices use were more likely to be associated with the frequent attendance at the 
ER. Further, most days regular intake of inhaled short B-agonist was more likely to be 
associated with frequent attendees and moderate/severe asthma compared to none regular 
use. For asthma severity, a hospital admission in less than a year ago was a strong risk 
factor. Under-treatment with inhaled beclomethasone, inability to obtain asthma medicines, 
most day regular intake of oral theophyline, and using 10-15 courses per year of oral 
steroids were more likely to be associated with moderate/severe asthmatics.  
Some variables showed to be significant in univariate analysis and still in multivariate. 
Meanwhile, others were not found to be significant in univariate nor in multivariate. The 
main results represented in this chapter are discussed in the coming chapter (chapter 6: 





Discussion and conclusion 
6.1 Introduction 
The present study is the first study in Palestine that is concerned with asthmatic patients in 
emergency rooms (ERs).  In Alia governmental hospital s ER in Hebron district we 
investigated the determinants that might be associated with frequent ER attendance in the 
past year and with asthma severity in the past three months. Furthermore, we evaluated the 
treatment adequacy of persistent asthmatics according to GINA 2002 guidelines (Ait-
Khaled and Enarson, 2005). 
6.2  Main results 
We found that asthma severity, indicators of severity (ever been admitted to hospital with 
asthma)  and reporting difficulty in asthma inhalers/devices use are more likely to be 
associated with the frequent ER attendees. We also found in univariate analysis that most 
days regular intake of inhaled short B-agonist (reliever therapy) was significantly more 
likely to be associated with frequent attendees and moderate/severe asthma compared to 
none regular use. 
For asthma severity, hospital admissions in less than a year ago and number of admissions 
(1-2 times or 3-4 times compared to no admission) were strong risk factors. In univariate 
analysis, having 3-4 visits or more than 6 visits to a professional in the past year showed a 
significant association with frequent ER attendance, similarly for asthma severity. Having 
the last visit to a professional in the period one week to six months prior to current ER 
attendance was a significant predictor of frequent attendance to ER. However, for asthma 
severity, having this last visit in the period six months or less prior to current ER 
attendance was a predictor of moderate/severe asthma. 
Another main findings are; under-treatment with inhaled beclomethasone, get regular 
treatment, follow up with patient carer, inability to obtain asthma medicines, using other 
remedies for asthma, most day regular intake of oral theophyline, report having home 
inhalation equipment, report taking all their asthma medicines, and using 10-15 courses per 
year of oral steroids were all more likely to be associated with moderate/severe asthmatics. 
On the other hand, reporting beneficial results from doctor in managing asthma at home, 
and an occasional regular intake of inhaled steroid were less likely to be associated with 
moderate/severe asthmatics. 
In multivariate analysis, patients living in cities and refugee camps showed six fold risk to 
be frequent ER attendees compared to villages. Further, married and older ages ( 50 
years) patients were more likely to have moderate/severe asthma compared to single and 
younger ages (5-19 years) patients; respectively. Meanwhile, higher levels of schooling 
( 10 years) and being on a monthly-based salary employee or school-students were less 
likely to have moderate/severe asthma compared to lower level of schooling (0-6 years) 
and being unemployed; respectively. 
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6.3  Asthma severity 
One of the main findings of this study was that the severity of asthma is a strong 
determinant for the frequent ER attendance in the univariate analysis. However, after 
adjustment for place of residence, health services utilization variables, and medications 
intake, it did not remain a significant factor (3 folds compared to mild asthma).  Also ever 
been admitted to hospital in the past was also a strong factor for frequent ER attendance 
(17 folds compared to one time attendance).  However, for asthma severity, hospital 
admissions in less than a year ago and number of admissions (1-2 times or 3-4 times 
compared to no admission) were strong risk factors. 
Our results are consistent with other studies that identified disease severity as a predictor of 
frequent ER attendance and repeated relapse (Dales et al., 1995; Wakefield et al., 1997; 
Adams et al., 2000; Dianne et al., 2004). Our finding is also similar to studies that showed 
previous hospital admissions as a strong predictor for asthma severity, ER attendance and 
relapse (Emerman and Cydulka, 1995;  Carren et al., 1998; Adams et al., 2000; Ford et al., 
2001). As Ford et al. (Ford et al., 2001) concluded, our results point to consider frequent 
ER attendees a group of asthma patients who have more severe, poorly controlled and 
managed asthma . 
Furthermore, mild asthma was seen in 54.5% of patients (n=66) and 45.5% of patients 
(n=55) had moderate/severe asthma. In our study persistent asthmatics were 92%. Burney 
et al. (2004, unpublished) found that 78% of the patients attended ER for asthma had 
persistent asthma; another recent study in USA found that they were 67% (Kelly et al., 
2004).  But these studies investigated higher number of patients; i.e. >1000. Furthermore, 
Classification of asthma severity in the previous three months was determined by self-
reported day/night time symptoms according to GINA 2002 guidelines (GINA, 2002) 
which varies by the reported history of daytime and/or nighttime symptoms (Ford et al., 
2001).   
6.4 Health services utilization 
In this study risk factors related to health services utilization at the health care system for 
asthma patients were identified. In the univariate analysis, the number of times in attending 
ER the past year was more likely to be associated with moderate/severe asthma.  Hospital 
admissions in less than a year ago and number of admissions (1-2 times or 3-4 times 
compared to no admission) were also significant predictors of moderate/severe asthma. 
Meanwhile, 1-2 times or 3-4 times of hospital admissions compared to no admission were 
also significant predictors of frequent ER attendance. These factors were shown in the 
univariate analysis as possible indicators for managing and controlling asthma severity. 
However, after adjustment these factors did not remain significant.  
Our findings are consistent with other similar studies (Emerman and Cydulka, 1995;  
Carren et al., 1998; Adams et al., 2000; Ford et al., 2001) that showed asthma severity, 
previous hospital admissions in the past year and two or more admissions as strong 
predictors for frequent ER attendance and relapse. Moreover, Adams et al. (Adam et al., 
2000) examined 293 patients with moderate to severe asthma attending the ER, found that 




6.4.1 Professional visiting: 
In univariate analysis, having 3-4 visits or more than 6 visits to a professional in the past 
year showed a significant association with frequent ER attendance, similarly for asthma 
severity. Having the last visit to a professional in the period one week to six months prior 
to current ER attendance was a significant predictor of frequent attendance to ER. For 
asthma severity, having this last visit in the period six months or less prior to current ER 
attendance was a predictor of moderate/severe asthma. 
Our findings are consistent with Ford et al. study (Ford et al., 2001) that showed a strong 
relation between scheduled visits to a physician's office in the previous year for asthma and 
frequency of ER attendance, since it might be as indicators of severity. Ford et al. (2001) 
repeated the analysis controlling for asthma severity and here again he had the same 
conclusion. However, when we controlled for asthma severity and other variables visiting a 
professional did not remain a significant predictor for frequent ER attendance. 
Interestingly, about 42% of the patients had their last visit to professional one week to one 
month before current ER attendance. The professionals' inability to prevent this current 
attack to those patients might be questionable.  A possible explanation is that disease 
severity and/or patient's poor self-management of their asthma led to current attack. 
Another explanation is that, professionals themselves might fail to properly managing 
those patients's asthma. Dependently, further analysis to this group of patients might be 
required to find out the proper explanation. 
6.4.2  Follow up, and health insurance:   
One of the main findings of our study is that given a letter to the usual carer is a predictor 
factor for frequent attendance at the ER compared to not given this letter. Although this 
factor did not remain significant after adjustment but it still shows four times fold 
increased risk for frequent ER attendance. Meanwhile, given a letter to usual carer it self 
remains a significant predictor of moderate/severe asthma after adjusting. Similarly, 
moderate/severe asthmatics were shown to get regular treatment for asthma compared to 
mild asthmatic after adjustment. Moreover, moderate/severe asthma were more likely to be 
followed on regular basis in univariate analysis.  
Using same facility for following up their asthma, patient having asthma severe level 
reported going to same facility more frequently compared to less severe asthmatics. 
In GINA guidelines (GINA, 2002) it is recommend for asthmatic patients at ER to have a 
close medical follow up including a letter to the career, and a written asthma action plan. 
Management plan was given to only 9% of the attendees in our study. A study in United 
States of America (USA) found that only 48% of those attended the ER for asthma had an 
action plan (Kelly et al., 2004). Another study in Argentina reported that 43% asthmatic 
patients were provided by management plan by their physicians (Raimondi et al., 2005). 
This rises up questions regarding the management plans and guidelines that are used at the 
Palestinian ERs for having a follow up of asthma patients. A more possible explanation, 
and since 96.7% of our study participants had health insurance, patients get their regular 
treatment at the ER which means that their regular carer was at the ER and thus no need for 
a letter for follow up. Our data concerning health insurance might contradicts other studies 
findings (Oster and Bindman, 2003; Raimondi et al., 2005) that reported higher rates of  
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ER attendances  among  uninsured patients because  they are less likely to have follow up 
and regular medical care. 
However, our findings were consistent with other studies in USA that found of 3612 
patients attending the ERs for asthma, 96.3% were insured ones (Ponda et al., February 
2005).  We  believed  that health insurance is varied from one country to another as a risk 
factor or predictor factor to frequent ER attendance  and that having access to health 
services does not necessarily ensure a good quality of care. This might be true because 
64% of our respondents reported to have access to specialist care and only 14% had 
medication review in past year and their insurance covers asthma drugs. Moreover, this 
might be influenced by the settings where the study was carried out, whether public or 
private hospitals and insurance coverage. For example; in Hebron district 70% of the 
population is covered by health insurance (Head of health insurance department-Hebron, 
October 2005, Private communication). 
In Palestine and especially after the current crisis (AL Aqsa Intifada) an overload on the 
governmental health services occurred. Thus patients have access to health services but the 
quality of these services is likely to be poor. Another possible explanation to our result is 
that insured patients might just find it an easy way to go to the hospital ER rather than 
taking, buying their medicines, avoiding trigger's factors, and other self-management 
procedures. Thus addressing the psychological factors may be needed to be investigated in 
a future study (Peleg et al., 2002; Dianne et al., 2004). 
Studies indicated that regular medical review led to a reduced number of ER visits 
(Gibson, 2000; Sulaimana et al., 2004) and as only 14% of our participants had medication 
review in past year, and 17% were followed on regular basis who were mainly 
moderate/severe asthmatics, this might be addressed in any future intervention program to 
reduce or even prevent ER attendance in Palestine. 
The findings of this study revealed that frequent ER attendees are more likely to use same 
facilitate often when have asthma attack than one-time attendees. This again implies that 
frequent attendees who were mainly insured ones simply prefer to rely often on the same 
hospital ER when have asthma attacks. Studies showed that those whom source of care is 
ER don t have an established source of primary health care (PHC) but only ER physicians 
who only care for emergencies (Singh A, Woodruff P et al., 1999). In our study only 18% 
of our participants always use the PHC facilities and 28% go either to private, public 
and/or out-patient clinic. This raises a question of whether the remaining 54% don't have a 
PHC or they just prefer the hospital ER for usual care (Ford et al., 2001).  Another study in 
Argentina found that 26% of ER attended asthmatic patients use ER as their routine care 
(Raimondi et al., 2005). 
Paying fully for medications was also shown to be inversely associated (not significant) 
with frequent and moderate/severe attendees to ER.  This was most probably the case, 
since frequent attendees to ER were mainly the severe cases. Consequently, the severe 
cases were found to be more likely to get regular treatment.  Accordingly, they might have 
a more chance to take their medications either on free of charge or on partial payment by 
their insurance. However, this by itself does not insure a proper treatment for those patients 
(Burney et al., 2004, unpublished).  
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6.4.3  Patients' education and specialist care: 
The results of our study show that only 44.6% of the sample population reported beneficial 
results from the doctor in managing their asthma at home. Reporting such beneficial results 
was significantly inversely associated with frequent attendees to ER. Similar results were 
shown with asthma severity even after adjustment.   Additionally, using inhalers and/or 
devices were reported to be difficult to be used by 44% of the study population. Frequent 
attendees were significantly more likely to report such difficulty after adjustment. 
Our findings are similar to other studies (Bailey et al., 1990; Belda, 1995; Peleg et al., 
2002; Dianne et al., 2004,) that indicated inability and lack of proper use of inhalers 
medication are significant predictors for frequent ER attendance. In this part of finding we 
were able to identify a modifiable reason for frequent ER attendance and that patient's 
education about asthma medication usage especially inhaled medications could be essential 
in any future intervention to reduce or prevent frequent attendance to ER (Boulet et al., 
1996; Peleg et al., 2002; Dianne et al., 2004). Another study concluded that doctors need to 
explore and acknowledge their patients personal disease experience and opinions and to 
respect a patients interpretation of their symptoms (Clark and Gong, 2000). 
Regardless of ER frequency attendance and/or asthma severity, only 35% of our ER 
attendees received training in inhalers use, 18% were given oral/written information about 
asthma, 23% reported to understand the difference between relievers/preventers 
medication, and 40% reported to ask doctor about asthma drugs. 
From our study results we could also conclude that patients attending ER showed lesser 
knowledge of asthma control criteria, as well as over all trend toward reduced asthma 
management knowledge and skills (Boulet et al., 1996). But they were like to have more 
information about asthma and its medications. Similar to other studies we could conclude 
also that poor understanding of the disease process or medication's work and  lack of 
disease management are a major problem for patients with asthma attending the ER 
(NHLBI, 1991; Dales et al., 1995; Kolbe et al., 1997). 
Only 25% of the study population reported to have home inhalation equipment. This was 
not significant regarding frequent and one-time ER attendees, while a significant 
association was observed in univariate analysis regarding asthma severity, i.e. 
moderate/severe asthmatics were significantly more likely to report having home 
inhalation equipment compared not to have it. A possible explanation is that either doctors 
prescribed this inhalation equipment to them and/or disease severity encourages those 
patients to buy this inhalation equipment. However, further analysis to this group of 
patients may be required to see whether they failed to use this equipment properly in order 
to prevent their current attack or they had more severe disease that could not be controlled 
by this inhalation equipment and/or they just relied on  ER care without trying  any home 
management procedures for asthma. 
We found also that 43% of the total was followed by a specialist, and only 21% of our 
participants were followed by an allergy/asthma and chest specialist, nearly 23% were 
relied on ER doctor, and 24% on general practitioner as their usual source of care.  We did 
not find a significant association between either specialist or by field of specialty and ER 
frequency attendance nor asthma severity. Although this contradicts other studies that 
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reported lack of asthma or allergy care specialist as a predictor to ER attendance and re-
attendance (Zeiger et al., 1991;  Zeiger and Schatz, 2000; Dianne et al., 2004).  
6.4.4  Compliance with medications: 
Compliance and adherence to asthma medications was found to be a problem of concern 
for asthma patients attending ER in our study.  Only 21% of our participants reported that 
they take all their asthma medicines. Moderate/severe was significantly more likely to 
report taking all their asthma medicines.  However, 76% of our participants reported to use 
other remedies in order to help their asthma, and this was significantly more likely to be 
associated with moderate/severe asthmatics even after adjustment. 
Another main finding in our study regarding asthma medicines compliance is that 43% of 
the total study population reported their inability to afford or obtain asthma medicines. 
While there was no significant difference by frequency of ER attendees, reporting not to be 
able to afford or obtain asthma medicines were shown to be significantly associated with 
moderate/severe asthma compared to not needing them. After adjusting, reporting not to be 
able to obtain these medicines remains a significant predictor of moderate/severe 
asthmatics. However, reporting not to be able to afford them showed nearly a two fold risk 
association but with no significance. 
A possible explanation for these findings could be related to the patients attempts to 
compensate their asthma medicines by other remedies as they failed to afford or obtain all 
their medicines or they might loss the hope in the prescribed medications.  However, 
further investigation might be required to determine the types of these remedies especially 
the herbal ones as they might worse asthma symptoms leading to exacerbations of asthma 
thus increase morbidity especially if they were not scientifically approved for asthma 
(GINA, 2002). 
Studies showed that as many as one half of asthma patients fail to adhere to daily treatment 
regimens either intentionally, unintentionally, or unknowingly (Sherman et al., 2000). 
Reasons for non-compliance to medications including; poor understanding, fear of steroids 
side effects, adolescence, low socio-economic status (Kolbe et al., 1997; Apter et al., 
1998), and psychological factors as a wish to be just like every one else (Balfour, 1999; 
Sherman et al., 2000). 
Many other studies indicated that non-compliance with prescribed medical regimens is 
contributing to asthma morbidity (Birkhead et al., 1989; Brooks et al., 1994; Rand and 
Wise, 1994; Milgrom et al., 1996). Our findings also represent this major problem in 
asthmatic patients attending the ERs. The  more severe asthmatics are those who required 
the more medications combination and have more loss of work thus contributing to low 
economic status of those patients and as a result, not to be able to buy their medications 
(Weiss et al., 1992; Krahn et al., 1996; Burney et al., 2004, Unpublished). Our findings 
concerning medications compliance should be considered in any future interventions to 
reduce ER attendance for asthma. 
6.5  Socio-demographic factors 
Of the 121 patients, 73.6% (n=89) were frequent ER attendees compared to 26.4% (n= 32) 
one-time ER attendees. In multivariate analysis, patients living in cities and refugee camps 
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showed six fold risk to be frequent ER attendees compared to villages, and no significant 
differences by sex, age, marital status, level of education, and occupation. 
Our findings might contradict other similar studies that indicated an association between 
attendance and low socio-demographic and economic status (Kolbe et al., 1997; Apter et 
al., 1998; Lara et al., 1999). A possible explanation to our result is that Alia hospital is 
located in the center of the city so most city patients find it easy to reach, while patients 
resident in villages might find it easier to go to primary healthcare centers distributed in 
their area. Additionally, no difference in the socio-economic status might be present 
between cities, villages and refugee camps in Palestine. 
Studies showed that women were on greater risk for ER attendance than men for asthma 
(Douglass et al., 2002) and in another study they were in a ratio of nearly 2:1 (Singh A, 
Cydulka R et al., 1999).  In our study we had nearly equal percentages of both male and 
female (52.9% vs. 47.1%; respectively) with no significant differences in ER attendance 
frequency. Undefined confounders, or small sample size, and/or because we carried our 
study in one setting (governmental hospital) might contribute to inability to detect the 
differences between ER attendees groups regarding socio-demographic factors. However, 
the population structure in Hebron district is unique in that it constitutes nearly equal 
percentages of males and females, i.e.  51.1% males and 48.9% females (MOH, 2005). 
In univariate analysis, married and  older ages ( 50 years) patients were more likely to 
have moderate/severe asthma compared to single and younger ages (5-19 years) patients; 
respectively. Meanwhile, higher levels of schooling ( 10 years) and being on a monthly-
based salary employee or school-students were less likely to have moderate/severe asthma 
compared to lower level of schooling (0-6 years) and being unemployed; respectively. 
However, this association might be a due to temporal relationship because of the study 
design and age as confounder as we did not adjust for it in univariate analysis.  
Our finding is in concordance with other studies (Apter et al., 1998; Ford et al., 2001; 
Dianne et al., 2002) that indicated low socio-economic status, married females and older 
patients are usually associated with greater exposure to causes and trigger factors arising 
from poor housing or financial barriers to quality of health services and medications for 
asthma thus contributing to asthma severity and morbidity. Interestingly enough, 61% of 
the patients in our study were having 0-6 years of education which might indicate poor 
knowledge of asthma and its medication. 
6.6  Asthma treatment protocol 
In this study we examined the association between asthma medications intake and frequent 
attendance at ER. Also we evaluate the association between these medications and asthma 
severity in the previous three months. However, special analysis has been done regarding 
treatment adequacy of persistent asthma by anti-inflammatory inhaled beclomethasone. 
6.6.1  Medications regularly taken in the past three months: 
6.6.1.1 Inhaled steroids: 
Our findings revealed that 89% of ER attendees relied on short B-agonist, while only 23% 
of them had taken inhaled steroids most days, and 27% occasionally in the previous three 
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months. Among frequent ER attendees, only 28% used inhaled steroids most days, 28% 
used them occasionally, and nearly 44% of them did not use inhaled steroids at all. 
In the univariate analysis we found that most days regular intake of inhaled short B-agonist 
and inhaled steroids were significantly more likely to be associated with frequent attendees 
and moderate/severe asthma compared to none regular use. However, in multivariate 
analysis we found that only an occasional regular intake of inhaled steroids was 
significantly inversely associated with moderate/severe compared to none use. Although 
the same association has been noticed for frequent attendees at ER regarding an occasional 
and most days regular intake of inhaled steroids the associations were not significant. 
Our finding is in concordance with previous studies that demonstrated a protective effect 
of inhaled steroids against asthma severity and morbidity (Taylor et al., 1990; Anis et al., 
2001; Suissa and Ernst, 2001). Therefore, our findings indicated the inhaled B-agonists as 
a predictor factor for frequent ER attendance, which is similar to other studies findings 
(Taylor et al., 1990; Dales et al., 1995; Anis et al., 2001; Eroglu G, Tugaeon A et al., 
2004), but not other (Dales et al., 1995; Eroglu G, Sulun F et al., 2004; Eroglu G, Tugaeon 
A et al., 2004;). This finding was not significant in the multivariate analysis. 
Moreover, only 23% used the inhaled steroids most days, and 27% occasionally, which 
was also in concordance with other studies that showed a range of 20-26% of patients 
attending the ER using it (Dales et al., 1995; Rabe et al., 2000; Bergquist and Crompton, 
2001; Eroglu G, Tugaeon A et al., 2004). However, only 60% of the moderate/severe 
asthmatics used it most days or occasionally and according to GINA it should be 100% 
(GINA, 2002). 
6.6.1.2 Oral steroids: 
We did not find a significant difference between frequent ER attendees and one-time 
attendees in the use oral steroid courses in the past year. However, using 10-15 courses per 
year of oral steroids was a significantly predictor of moderate/severe asthma. GINA 
guidelines (2002) recommended step up and step down therapy by oral steroids depending 
on asthma severity level and control. In Palestine each prescribed course of oral steroid 
contains 30 tablets, and if we compare this to the number of courses the moderate/severe 
asthma took in the past year  (10-15) we can conclude that those patients have a high 
continuous consumption of oral steroids, which is not according to GINA guidelines 
(GINA, 2002).  
6.6.1.3 Inhaled short B-agonist and beclomethasone use:  
GINA guidelines. (2002) recommended the use of inhaled short B-agonist as needed 
(during attacks) but not on daily basis. Our univariate results revealed that patients used 
currently 1 cannister/month of inhaled short B-agonist were at a significantly increased 
risk to be a frequent ER attendees and to have moderate/severe asthma compared to none 
current use. An inverse associations were observed between the study outcomes and using 
<1 cannister/month of inhaled short B-agonist.  
These findings support our previous ones (we found in univariate analysis that most days 
regular intake of inhaled short B-agonist was significantly more likely to be associated 
with frequent attendees and moderate/severe asthma compared to none regular use) and  
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are similar to other studies that related its use to frequent ER attendance and worsening of 
asthma control and increased ER visits and asthma morbidity (Taylor et al.,1990; Dales et 
al., 1995; Anis et al., 2001; Eroglu G, Tugaeon A et al., 2004). 
Studies showed that proper use of beclomethasone as a protective factor from ER 
attendance and as a good medication for control of asthma in specific (Dales et al., 1995; 
NHLBI, 1997; GINA, 2002; Eroglu G, Sulun F et al., February 2004; Eroglu G, Tugaeon 
A et al., 2004). However, inhaled beclomethasone does not necessarily predict to prevent 
ER attendance or decrease asthma morbidity unless it is used adequately and delivered in 
the context of proper dosage according to asthma severity level (NHLBI, 1997; GINA, 
2002; Burney et al., 2004, Unpublished). Meanwhile, many studies have reported under 
treatment by inhaled steroids which cause a worsening of asthma control leading to 
increased risk of ER visits (Taylor et al., 1990; Anis et al., 2001; Eroglu G, Tugaeon A et 
al., 2004).  We did support such studied as we found that only 37% of mild persistent 
asthma, 9.5% of moderate persistent, and no case of the severe persistent asthmatic were 
adequately treated by inhaled beclomethasone, and that moderate/severe persistent asthma 
were significantly less likely to be adequately treated by inhaled beclomethasone than mild 
persistent asthmatics. Even though, we do still  believe that a proper dosage of inhaled 
beclomethasone according to asthma severity level and GINA guidelines might reduce ER 
attendance and asthma morbidity and that there is a need to institute aggressive 
interventions to improve the quality of care for asthma (GINA, 2002; Ait-Khaled and 
Enarson, 2005). 
6.6.1.4 Theophyline: 
The recent international and national guidelines don't recommend but further doubt the 
effectiveness of theophyline in asthma management if it is not used in combination with 
other proper asthma medications (GINA, 2002; Abdeen et al., 2003; NHLBI, 2003).  
In our study 80% of moderate/severe asthmatics used oral theophyline compared to 54% of 
mild asthmatics.  After adjustment, this was shown as a predictor factor for 
moderate/severe asthma compared to none regular use.  This raised a question about the 
possibility that patients with severe asthma can not afford using the proper medications 
which leads to the use of a cheaper medications like theophyline. Another possible 
explanation is the poor effectiveness of this medication that is prescribed by the patient's 
physician, in controlling the patient asthma. .  
6.6.2  Medications discharged with:  
Since most patients came with their medications, prescription of medications did not 
exceed for 15%of the patients in general. But, an over prescription of antibiotics (50% of 
the patients) and cough mixtures (25% of the patients) were noticed. These findings 
contradict the GINA. (2002) and the American NAEPP guidelines. (1997) who indicated 
that antibiotics should be used only when bacterial infection is confirmed and that cough 
mixtures may worse asthma symptoms leading to exacerbation of asthma. Although the 
ERs are often busy facilities we would recommend them to be included in any future 
intervention program as the ER doctor can add inhaled steroids to patient's medications 
with the recommended proper dose together with long acting B-agonists leading to 
reduction in ER attendance for asthmatics (Singh A, Woodruff P et al., 1999; Walsh-Kelly 
et al., 2005).  
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6.7  Conclusions  
This study results are important in providing detailed information on patients attending the 
ER for asthma and the risk factors that are possibly associated with asthma morbidity and 
frequent attendance at ER of Alia governmental hospital in Hebron district. 
The study showed that the majority of the patients attending the ER of Alia hospital for 
asthma are used to attend the ER frequently. Patients living in cities and refugee camps 
showed six folds risks to be frequent ER attendees compared to villages although 
difference was not significant. Low socio-economic indicators such as lower level of 
education and being unemployed were more likely to be associated with severe asthma.  
The other outcome indicator for this study, i.e. asthma severity, was shown at the same 
time as a strong indicator for ER attendance. This indicates that frequent ER attendees 
represent a group of asthmatic patients with moderate/severe, poorly controlled and 
managed asthma. 
Another important issue that this study highlighted was the access to health services and 
the quality of care patients received at the ER. Our data suggest that having access to 
health services does not necessarily ensure a good quality of care and proper treatment. 
This might be also true as moderate/severe asthma were more likely to get regular 
treatment although this treatment was considered as an under-treated.  
Therefore, Alia ER is a proper target for an intervention program that aims to prevent or 
reduce ER attendances for asthmatics and also a place for teaching the sever patients how 
to manage their asthma properly. However, compliance and adherence to asthma 
medications should be considered for patients attending the ER for asthma especially those 
with the more sever disease. 
In summary, in general, poor understanding of the disease process or medication's proper 
functioning and use, inhalers/devices proper use and lack of disease management are major 
problems for patients with asthma in Palestine. Furthermore, over-reliance on short B-
agonists (reliever therapy) together with the under-treatment with inhaled steroids 
(controller therapy) might add to the risk factors for frequent ER usage and asthma 
morbidity. Meanwhile, oral steroids were not prescribed according to GINA guidelines; i.e. 
step up and step down (GINA, 2002) which might be contributed to asthma severity. 
Increasingly, moderate/sever patients might try to compensate for cheaper drugs 
(theophyline) instead of the more expensive and effective asthma medicines. However, 
effectiveness of theophyline in controlling and managing the more severe asthma should be 
reconsidered by the physicians. 
As a miss prescription of medications, an over prescription of antibiotics and cough 
mixtures (mucolytics) to asthma patients upon discharge don't substitute the effective and 
adequately prescribed anti-inflammatories, but could worse asthma symptoms especially 
cough mixtures (GINA, 2002; NHLBI, 2003). 
In brief, asthma severity and reporting difficulty in asthma inhalers/devices use are more 
likely to be associated with the frequent ER attendees.  Under-treatment with inhaled 
beclomethasone, get regular treatment, follow up with patient carer, inability to obtain 
asthma medicines, using other remedies for asthma, and most day regular intake of oral 
theophyline were all more likely to be associated with moderate/severe asthmatics. On the 
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other hand, reporting beneficial results from doctor in managing asthma at home, and an 




6.8  Recommendations 
The study researchers suggest the following recommendations for reducing or preventing 
ER attendance and its associated risk factors. 
1) Asthmatic patients should not only have access to healthcare services but an access to 
an improved quality of services. 
2) Primary health care physicians should address the socio-economic determinants of 
health for patients with asthma especially the more sever patients. This could be done 
through prescribing the less cost and most effective available preparations, avoiding 
improper and unnecessary drugs combinations. Also through educating patients how to 
avoid trigger factors, hygiene process, and usage of inhalers especially the married, 
less educated, and older ages patients.   
3) Exploring the barriers to financing and asthma medications could further stratify 
targeted interventions in reducing the ER attendance for asthmatics, and would increase 
patients' compliance and adherence to prescribed medications, specially in low socio-
economic status patients.  
4) Asthma should be pharmacologically-adequately managed and controlled according to 
established national and international guidelines, other wise further steps toward its 
control will be useless.  
5) Strengthen the role of primary health care in prevention and management of asthma. 
6) Construction of clear simple technically and clinically practiced national guidelines and 
protocols for asthma management. 
7) Raising the quality of health professionals by; continuous education and training of the 
medical staffs to improve performance, monitoring and evaluation of practice, 
increasing their adherence to asthma management guidelines for proper anti-
inflammatory use. 
8) Functional follow up and referral to asthma specialist for asthmatics after ER and 
hospital discharge as well as close medical review at specific time intervals. 
9) Asthma should be recognized as a major public health problem and a reportable disease 
at the national level through improvement of recording system and effective steps 
toward its control should be started. 
10) An ER and/or PHC based educational intervention program for asthma patients with an 
integral activity of all health workers concentrated on; 
1. Providing instructions for proper inhalers/devices technique and usage. 
2. Cultural aspects of inhalers use. 
3. Fears of steroids. 
4. Understanding of the disease process and medication's work as well as the 
implementation of asthma management plan. 
5. Proper pharmacotherapy of asthma according to severity level as well as addressing the 
importance of proper inhaled anti-inflammatory use rather than over-reliance on 
reliever medications especially for moderate/severe asthmatics.   
6. Importance of long term adherence to medications on reducing asthma morbidity. 
7. Patients' knowledge and skills about asthma control criteria.     
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6.9   Area for future research 
1. An intervention study with ER and/or primary care clinic-based asthma education 
program that addresses the deficiencies observed in this study and then evaluates 
asthma morbidity outcomes after the intervention program.  
2. A qualitative study that identifies doctors knowledge, attitudes and prescribing 
behaviour of asthma medications. 
3. A quantitative study that explores the economic evaluation of asthma with both direct 
and indirect costs. 
4. A study that evaluate the assessment and management of acute asthma in emergency 
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Appendix 4.3: The study questionnaire.
 
File Number:  
Demographic information
  
1-Hospital            1. Alia           2. Ramallah 
2- Date of arrival : ------/-----/------(Day/Month/Year)                 
3- Time of arrival:  --------:---------(Hours: Minutes) 
4- Patient s name: __________ ______________ ___________ 
                                            first middle last 
5- Patient s address:------------------------------------------------------------------------- 
6- Home phone:---------------------------      7- Cellular phone:--------------------
----   
8- Sex  1. Male       2. Female 
9- Place of residence:        1. City       2. Village      3. Refugee 
camp      
10- Marital status  1. Single 2. Married 
               3. Divorce
d            
4. Widowed 
11- Occupation:--------------------------------- 
                
12- Age  ___  ___ Years 13-  Height:  ___, __m 14- Weight:__ __ __, 
__Kg 
15- Highest level of education: 
1. (0-6) years of schooling 2. (7-9) years of schooling 
3. (10-12) years of schooling       4. >12 years of schooling 
Vital Characteristics   
16- Temperature: __ __, __ (ocentigrade) 17- Pulse: __ __(beats/minute) 
18- Respirations:  ___ __ (breaths/minute) 19- PaO2 (in Air) :  ___ ___   
    
20- SaO2 (in Air):  ___ ___ 21- PaCO2 (in air):  ___ ___ 
22- Peak Expiratory Flow Rate (before salbutamol): 
___ ___ ___ __  (L/min) 
23- PEF1 (% predicted): ______%        
24- Peak Expiratory Flow Rate (2 hrs after salbutamol): 
___ ___ ___ __  (L/min) 
25- PEF2 (% predicted): ______%        
26- Time since asthma attack began:  
1. >24 hrs                  2. 3-24 hrs 3. <3 hrs  
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27- Repeat appearance of this patient in this study? 0.  No       1. Yes  
28- At the time of attending the ER, the patient status was  
Answer code (1) (2) (3) (4) 
a. Breathless None On lying     
down 
On talking At rest 
b. Wheeze Only end 
expiratory 
Continuous Loud Absent 
c. Can speak in Sentences Phrases only Words 
only 
Impossible 
d. Accessory     
Muscle use 




e. Mental State Alert Agitated Confused Comatose 
f. Oxygen:                 1. No         2.  28%                 3. >28% 
g. Systemic steroid:    1. Oral 2. Intramuscular 3. intravenous    
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29- Patient s Medications
 
i- Regularly take  
(0) None 
(1) Occasionally 
(2) Most days 
ii-Receive in   
hospital 
(0) No  
(1) Yes 
iii- Discharged with 
(0)  None 
(1)  Prescription 
(2)   Medication 
Oral 
a. Anti-biotics    
b. Anti-histamine      
c. Anti-leukotriene    
d. Cough mixtures    
e. Sedatives    
f. Short acting B-agonist    
g. Steroid    
h. Theophylline    
Inhaled 
i. Anti-cholinergic    
j. Cromoglicate    
k. Short acting B-agonist    
l. Long-acting B-agonist    
m. Steroid    
Parenteral 
n. B2-agonist    
o. magnesium    
p. methylxanthine    
q. Sedatives    
r. Steroid    
Nebulized 
s. Anti-cholinergic    
t. Short acting B-agonist    
Others 
u. Intubation/IPPV    
v. Oxygen    
30- Does the patient take cardiac medications (circle all right answers) 
1. None 2. Anti-hypertensives 
3. Diuretics  4. Beta-blockers   
31- Does the patient take psychiatric medications? (circle all right answers) 
1. None  2. Sedatives/ Minor tranquilisers  
3. Anti-depressants 4. Anti-psychotic/ Major tranquilisers     
32- How many courses of oral steroid has the patient taken in the past year? ------------ 
33- Does the patient use steroids? 
1. None 2. Beclomethasone  500mcg/day 
3. Beclomethasone 1000mcg/day        4. Beclomethasone  2000mcg/day    
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34- Does the patient use short acting B2-agonist? 
1. None 2. < 1 cannister/ month 
3.  1 cannister/ month     
35- Are you currently using any remedies, other than conventional medicines, to help your 
asthma? (not nasal symptoms) 
0. No  1. Yes 
36- Over the 3 months before this attack began, how often did your asthma: 
1. Every or     
almost every  
2. More 
than  once 
a week  
3. At least 
twice a 
month  
4. Less than 




a) Wake you up (night)?      
b) Give you trouble 
breathing (day)?      
c) Prevent you 
working/carrying out 
usual activities (day)?       
37-  0. No 1. Yes 
(a) Have you ever had eczema and/or Rhinitis?   
(b) Have you ever had a skin prick test allergy test before?   
(c) Have you ever had a lung function test before?   
(d) Do you have a spirometer or a peak flow monitor at home?   
(e) Have you ever been diagnosed with asthma?   
(f) Do you suffer symptoms of asthma only during a particular season?   
(g) Do you suffer symptoms of asthma at any time of the year?   
  
38- How old were you when you first diagnosed with asthma? ________ 
years  
39- Where did you have first been diagnosed?  
1. At the clinic 2. At the hospital clinic 3. At the hospital ER 
40- By whom have you been diagnosed?              
1. General doctor 2. Specialized doctor 
41- Has this patient visited an ER room before with  0. No 
asthma? 1. YES, less than a year ago      
2. YES, more than a year ago  
 
42- How many times have you attended the ER in the past year? ____ times  
43- Has this patient ever been admitted to hospital  0. No 
with asthma? 1. YES, less than a year ago      
2. YES, more than a year ago  
44- How many times have you been admitted the 
hospital with asthma in the past year?              
_____ times  
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45-  0.  No 1. Yes 
a. Does the patient get regular treatment for asthma?   
b. Does the patient followed on regular basis?   
c. Does the patient go to the same facility always?         
                  if yes, specify-------------------------   
d. Does the patient has health insurance?   
e. Does this insurance cover asthma drugs?   
f. Do you have access to specialist care?   
g. Does the patient has a follow up, appointment for    
                example, after he leaves the emergency room?
 
46- How much does the patient pay for their medicines?  
1. Free  2. Partially covered  3. Full cost  
 
47- Who is mainly responsible for following up your asthma?         
1. Specialist 2. ER doctor      3. GP 
4. Nurse 5. Others  
48- If a specialist, what was his/her field of speciality? ---------------------- 
49- Where does your doctor work?      
1. Public 2. Private      3. UNRWA 
4. NGO                  5. Charitable  
50- Where does your doctor work?      
1. This hospital               2. health care centre  3. Another hospital   
4. Private clinic   
      
51- How many times have you visited a professional in the past year?  ______ times 
52- When was this patient last seen by them? 
1. <1 week ago      2. 1 week to 1 month ago 3. >1mnt-6 mnt ago                                                             
4. >6 mnt to 1 year ago 5. > 1 year ago  
53- How many attacks of asthma have you had in the past year? _____ times 
54- Does the patient use the same facilitate when he has attacks? 
1. Always 2. Often 3. Sometimes 
4. Rarely 5. Never  
55-  0. No 1. Yes 
a. Do you benefit from seeing your doctor in managing your 
asthma at home?   
b. Do you ask the doctor questions about asthma 
medications?   
c. Did you have medication review in the past year?   
d. Have you been given information (oral/written) in the past 
on asthma?   
e. Do you understand how each medication works (relievers/ 
presenters)?   
f. Do you have home inhalation equipment?   
  
99
g. Would you like to have more information on asthma 
disease?   
h. Would you like to have more information on asthma 
medications/devices?   
i. Did the patient receive a MANAGEMENT PLAN   
j. Did patient receive training in inhaler use?   
k. Was the patient s usual carer sent a letter?   
l. Does the patient take all their medicines?            
  
56- How do you find the inhalers/devices are to use?   
1. Easy 2. Difficult 
57- How could you describe your relationship with your doctor at the clinic? 
1. Good 2. Poor 3. No regular doctor 
58- Why do you attend the ER? 0. No 1. Yes 
a. Respiratory infection   
b. Shortness of breath   
c. Less medication  cost   
d. Misuse of asthma medication   
e. Worried about asthma symptoms   
f. others   
 If yes, specify 
                        ----------------------------------------------------------  
59- Why do not you use all your medication?  
1. Don t need them                2. Can t afford them      3. Can t obtain them               
4. Don t want them    
60- Your regular practitioner name and address 
____________________________________________________________________________
____________________________________________________________________________ 
61- Patient:                                                                       1. Discharged       2. Admitted  
62- Patient Discharge:         1. Alive             2. Dead  
63- Date of discharge:   -------/------/------- (Day/Month/Year)  
64- Time of discharge:   -------- :-------------(Hours: Minutes)   
